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Abstract
The purpose of this thesis was to examine the longitudinal associations between body mass
and depressive symptoms as adolescents transition into young adults, using secondary data
analysis of the National Longitudinal Survey of Children and Youth. Adolescents (N =
1,895) were followed across five ages, between ages 17 and 25. Body mass and depressive
symptoms were self-reported at each age. Latent growth modelling was used for all analyses.
Results showed that the trajectory of body mass increased over time, while the trajectory of
depressive symptoms decreased over time, for both males and females. Adolescent females
with higher initial body mass levels reported a slower decrease in depressive symptoms over
time. Conversely, adolescent males with higher initial depressive symptoms reported a
slower increase in body mass over time. Public health implications, future research
initiatives, and conclusions are further discussed.
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Chapter 1

1

Background

1.1 Body mass and depressive symptoms
Among Canadian adolescents, both body mass and depressive symptoms have
become increasingly significant public health concerns, as respective increases in these
health outcomes place individuals at heightened risk of becoming overweight/obese and
1

developing clinically significant depressive symptoms (Roberts, Lewinsohn, and Seeley,
1991; Shields, 2006). Over the past three and a half decades, the prevalence of obesity
has increased substantially in economically developed countries such as Canada
(Lobstein, Baur, & Uauy, 2004). Particularly alarming is the rate of increase in
adolescents and young adults. According to a nationally representative sample of
Canadians, the obesity rate for adolescents aged 12-17 tripled between 1978 and 2004,
from 3% to 9% (Shields, 2006). Although obesity is increasing in all age groups, young
adults aged 18 to 29 are experiencing the highest rate of increase (Mokdad, Serdula,
Dietz, et al., 1999). In Canada, the obesity rate for 25-34 year olds more than doubled
from 1978 (9%) to 2004 (21%; Tjepkema, 2006). In a 2007 national survey of Canadians,
6.4% of 18-19 year olds and 11% of 20-24 year olds were classified as obese (Shields,
2008). The obesity rate for 18-29 year olds in the United States increased from 7.1% in
1991 to 12.1% in 1998 (Mokdad et al., 1999). The increased prevalence of obesity in
adolescence and young adulthood has been linked to the concurrent rise of many physical
health problems normally associated with adults, including type 2 diabetes,

1

Note, there is a difference between depressive symptoms and clinically significant depressive symptoms.
Depressive symptoms are defined as any one or more symptoms identified in validated depressive
symptom scale(s) (e.g., decreased enjoyment of pleasurable activities, low self-esteem, hopelessness,
apathy, difficulty sleeping, etc.,), with higher scores (across the entire continuum of scores) indicating
higher depressive symptoms (Radloff, 1977). Clinically significant depressive symptoms are defined as an
established cut point in depressive symptom scales used to distinguish a sufficient amount of depressive
symptomology to closely resemble clinically depressed patients in treatment (Berkman, Berkman, Kasl, et
al., 1986). For example, using the Center for Epidemiological Studies- Depression Scale (CES-D; Radloff,
1977), a cut point of greater than or equal to 22 for adolescent males and 24 for adolescent females is
suggested to identify cases of Diagnostic and Statistical Manual III- Revised (DSM-III-R) major depression
and dysthymia (Roberts, Lewinsohn, and Seeley, 1991).
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cardiovascular disease, hypertension and stroke, and certain forms of cancer (World
Health Organization [WHO], 2003).
In addition to increases in body mass, depressive symptoms during adolescence
are also common (Birmaher, Ryan, Williamson, et al., 1996). In fact, late adolescence has
been reported to be the period of the lifespan with the greatest experience of depressive
symptoms (Wight, Sepúlveda, & Anashensel, 2004). Following a peak at about age 16 to
17 years of age, depressive symptoms tend to gradually decline into young adulthood
(Ge, Natsuaki, & Conger, 2006; Wight et al., 2004). Depressive symptoms during
adolescence and young adulthood include decreased enjoyment of pleasurable activities,
low self-esteem, hopelessness, apathy, and difficulty sleeping (Radloff, 1977). At
particular cutoffs, these symptoms have been shown to predict the development of major
depression disorder (Georgiades, Lewinsohn, Monroe, & Seeley, 2006), which in turn has
been associated with increased risk of coronary heart disease, myocardial infarction, and
mortality (Birmaher, Brent, Bernet, et al., 2007; Birmaher, Williamson, Dahl, et al., 2004;
Brent, 2006; Faith, Matz, & Jorge, 2002; Williamson, Birmaher, Brent, et al., 2000).

1.2 Adolescence and young adulthood
Keeping these particular health outcomes in mind, there has recently been
growing awareness of the importance of the life course perspective in public health
research. Increasingly, evidence has shown that factors operating at special critical
periods earlier in life may influence health at later periods in the life course (Osler, 2006).
By utilizing a life course perspective, the influence of a risk factor in one stage of life can
be examined as individuals proceed into the next phase of life (Merten, Wichrama, &
Williams, 2008).
Adolescence and young adulthood are both particularly important developmental
periods to consider when examining the course and co-occurrence of both body mass and
depressive symptoms. Adolescence is a sensitive period of development, during which
the influence of positive or negative experiences may have a lasting effect throughout the
lifespan (Bornstein, 1989). Developmental psychologists consider adolescence an
important life-stage to study because of the critical changes that mark this period of
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development, especially as a result of puberty (Dahl, 2004). More specifically, puberty is
linked to physical changes in body size (Dahl, 2004), making adolescence a
developmental period for increased weight, as well as the onset and persistence of obesity
(Dietz, 1994). In addition to physical changes in body size, adolescence is also marked as
a period of heightened emotions (Dahl, 2004). Because of this natural tendency toward
high-intensity feelings, it is not surprising that there is an increase in the onset of
internalizing problems, such as depressive symptoms, within this age group (Elliott,
Huizinga, & Menard, 1989; Kandel & Davies, 1982).
Young adulthood, on the other hand, is a developmental stage characterized by
increased educational endeavours, establishing employment, and establishing and
maintaining interpersonal and intimate relationships (Merten et al., 2008). Young
adulthood marks the point in time where major transitional changes occur. For example,
across the lifespan young adulthood is the period with the highest level of fertility, the
highest marriage rates, the highest rates for leaving school, and the highest residential
migration rates (Rindfuss, 1991). For the majority of young adults, major decisions and
role changes occur in most areas of life and are occurring in a relatively short and
overlapping period, making this time in the life course particularly dynamic (Rindfuss,
1991). Individuals in this life stage have much more independence over important life
choices, such as physical activity, dietary intake, and participation in healthy or unhealthy
behaviors (e.g., binge drinking, smoking; Kemper, Post, Twisk, & van Mechelen, 1999),
all of which affect physical health. With regards to mental health, young adults also
acquire a significantly greater capacity for integrating thought and emotion, allowing for
greater emotional regulation than they had as adolescents.
In addition to period-specific changes that occur during adolescence and young
adulthood, large and complex changes also occur as adolescents transition into young
adults. Increases in body mass among adolescents and young adults in particular is a
major health concern because overweight and obese conditions in these developmental
stages tend to persist into adulthood (Whitaker, Wright, Pepe, Seidal, & Dietz, 1997). For
example, researchers have reported that more than 70% of obese adolescents become
obese adults (Guo, Roche, Chumlea, Gardner, & Siervogel, 1994). In addition, daily
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physical activity tends to decrease from adolescence into young adulthood, whereas fat
mass gradually increases (Kemper et al., 1999). In a longitudinal study, Kemper and
colleagues (1999), reported that while less than 10% of males were classified as obese at
age 13-16, by the time these individuals were 32 years old, this percentage doubled to
20%. For females, increases in obesity went from 10% at ages 12-16 to 30% at age 32.
Overall, the increase in body mass as well as the decrease in depressive symptoms that
occur as adolescents become young adults, illustrate that the transition from adolescence
to young adulthood with respect to these health outcomes is an important developmental
period on which to focus academic attention (Sampson & Mrazek, 2001).

1.3 Objective and rationale
While the links between body mass and physical health have been established, the
same is not true for relations with psychological health indices such as depressive
symptoms (Hill, 2005). Recently however, the high prevalence of obesity and depression
has led researchers to examine potential associations between the two. Although there is
some research on the cross-sectional relationship between body mass and depressive
symptoms (Baumeister & Härter, 2007; Faith et al., 2002; John, Meyer, Hapke, Rumpf,
& Schumann, 2004), it is still unclear how these two health outcomes interact over time
(Faith, Butryn, Wadden et al., 2011; Liem, Sauer, Oldehinkel, & Stolk, 2008).
In addition, there is no consistency in the literature regarding the role of sex on
these associations, especially during the transition from adolescence to young adulthood.
These are important research questions to address for two primary reasons. First, body
mass and depressive symptoms are both dynamic developmental processes that change
across the lifespan (Needham, Epel, Adler, & Kiefe, 2010), and thus should be examined
prospectively within a developmental framework in order to identify important changes.
Second, body mass (Shields, 2006) and depressive symptoms (Kuczmarski, Ogden, Guo,
et al., 2002; Locke & Newcomb, 2001) are both differentially distributed based on sex,
thus longitudinal associations between the two may drastically vary for males and
females.
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Studying how body mass and depressive symptoms independently change, as well
as how they are associated over time, will aid in understanding the course and
consequences of both health outcomes. Furthermore, an important research and public
health question to address is whether there is a causal relation between both body mass
and depressive symptoms in the transition from adolescence to young adulthood, and
whether these associations are similar for males and females. In a recent review, Liem
and colleagues (2008) suggested that identifying treatable predictors such as depressive
symptoms could lead to better outcomes for preventing and treating overweight and
obesity later in life. In similar respects, psychological issues may be preventable by
addressing physical health and body weight issues early on. Understanding the sex
differences in these associations may help determine when, and to whom, resources
should be targeted at to effectively prevent negative health outcomes later in life. Overall,
given the toll that both body mass and depressive symptoms have on an individual’s
quality of life and functioning, as well as the persistence and lifecourse stability both tend
to have into adulthood (Bradley, Houts, Nader, et al., 2008), it is important to explore the
potential links between them and target public health prevention strategies to help
mitigate future adverse health outcomes (Calamaro & Waite, 2009).
With these public health implications in mind, the objective of this thesis is
examine the longitudinal associations between body mass and depressive symptoms
during the transition from adolescence to young adulthood, and to investigate if and how
these associations differ for males and females. By examining the relationship between
body mass and depressive symptoms over time, we can determine whether longitudinal
associations exist, as well as whether one health outcome better predicts the other. As
previously mentioned, understanding the longitudinal associations between body mass
and depressive symptoms may be an important step in identifying risk factors to target in
prevention strategies aimed at increasing the physical and psychological well-being of
adolescents and young adults (Clark, Haines, Head, et al., 2007).
Few prospective studies have effectively evaluated this research question, and
even fewer have focused on the developmentally important transition from adolescence
to young adulthood. That is, while associations in adulthood have been heavily
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researched (Bjerkeset, Romundstad, Evans, et al., 2008; Forman-Hoffman, Yankey,
Hillis, Wallace, & Wolinsky, 2007; Gariepy, Wang, Lesage, & Schmitz, 2010; Needham
et al., 2010; Roberts, Deleger, Strawbridge, & Kaplan, 2003), very little is known about
the effect weight status has on the decrease in depressive symptoms across late
adolescence and young adulthood, as well as the effect depressive symptoms have on the
increase in weight across late adolescence and young adulthood. Thus, there is a need for
well-formulated longitudinal research to examine the predictive direction of these
associations across these developmental periods.
The rest of this thesis will be organized in the following order: groups of
theoretical models accounting for the prospective association between body mass and
depressive symptoms, longitudinal research on the association between body mass and
depressive symptoms, current plan of study, methods, results, and discussion. First, two
major groups of theoretical models accounting for the prospective association between
body mass and depressive symptoms will be presented with a focus on the adolescent and
young adulthood developmental periods. Next, a literature review covering longitudinal
research that has assessed the directions of association between body mass and depressive
symptoms will be presented, as well as a summary of the limitations with current
research in this area. Following this literature review and summary, a plan of study, along
with specific objectives and hypotheses will be presented. Next, methodological topics
covering the data source, variables used, and analyses will be discussed. Finally, the
results will be presented, along with a discussion of findings and recommendations for
future research. Important sex differences in the association between body mass and
depressive symptoms will be highlighted throughout all sections.
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Chapter 2

2

Literature review

2.1 Theoretical models accounting for the prospective
association between body mass and depressive
symptoms
The purpose of this literature review is to examine the empirical evidence
assessing the direction of association between body mass and depressive symptoms in
adolescents and young adults. There are two major groups of theoretical models that
explain the prospective association between body mass and depressive symptoms. The
first group describes how increases in body mass may lead to increases in depressive
symptoms over time. The second group describes how increases in depressive symptoms
may lead to increases in body mass over time. Each of these models will be explained in
detail below.

2.1.1

Body mass affecting depressive symptoms
There are many possible causal pathways, both psychologically and physically,

that may lead adolescents and young adults with higher body mass to develop increases
in depressive symptoms over time. These include the internalization of biased attitudes
towards weight, weight-teasing, neurobiological causal pathways, and functional
impairment. Each of these causal pathways will be explained in greater detail below.

2.1.1.1

Internalization of biased attitudes

According to the reflected self-appraisal hypothesis, an individual’s self-concept
(i.e., his/her internalized view of himself/herself) is socially constructed through selfappraisals and the judgments of others (Hayes & Ross, 1986; Ross, 1994). According to
the social comparison theory, individuals engage in a continuous process whereby they
compare themselves to people with whom they believe possess desirable traits (Festinger,
1954). Thus, the thoughts and feelings individuals have about their body are constantly
affected by social influences and the comparisons they make with others.
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Since overweight status is perceived as a less attractive and more stigmatizing
characteristic in Western cultures (Hill, 2005), individuals with higher body mass may
internalize the negative attitudes of society towards their weight, resulting in lower selfesteem and higher psychological distress (Ross, 1994). Studies on stereotyping have
shown that obese individuals are viewed as being undisciplined, inactive, and
unappealing (Hill, 2005). These stereotypes may be especially prominent during
adolescence (Bradley et al., 2008) given the dramatic changes in cognitive functioning
and physical development. In fact, these negative views tend to be held by people who
are younger (Hill, 2005), placing heavier adolescents and young adults at a higher risk of
being stereotyped by their peers. Thus, body mass may affect depressive symptoms
through an internalization of biased attitudes from peer, family, and society towards the
individual.
Internalization of biased attitudes may be more prominent in females compared to
males (Wadden & Stunkard, 1987), especially during adolescence and young adulthood.
For adolescent boys, most of the weight gain as a result of puberty is explained by
increases in muscle tissue, whereas weight gain for adolescent girls is mostly explained
by significant fat mass deposition in the abdomen, buttock, and thigh regions (Tanner,
1989). Overall, fat mass increase during this developmental period is significantly greater
in females than males (Xie, Unger, Gallager, et al., 2010). Females also tend to place a
great deal of subjective importance on their physical appearance (Wadden & Stunkard,
1987). This increase in fat mass, paired with high levels of self-consciousness and
embarrassment about the physical changes that accompany puberty, may place adolescent
girls at a higher risk for the development of body image issues as well as increases in
depressive symptoms over time (Wadden & Stunkard, 1987).

2.1.1.2

Weight-teasing

Weight teasing toward heavier individuals has been reported among health
professionals, peers, and family members (Cash, 1995; Neumark-Sztainer, Story, &
Faibisch, 1998). In fact, ‘fat-teasing’ is reported by one in seven adolescents (Hill, 2005).
One study reported that, for females, weight teasing in middle adolescence was
associated with lower self-esteem, lower body satisfaction, and marginally higher

9

depressive symptoms in young adulthood (Eisenberg, Neumark-Sztainer, Haines, &
Wall, 2006). For males however, weight-teasing in middle adolescence did not
prospectively predict increases in depressive symptoms during young adulthood,
although it did predict lower body satisfaction. Thus, depressive symptoms may develop
through poorer peer relationships and an increased dissatisfaction with appearance. The
resulting poor peer relationships are also associated with poorer mental health (Hill,
2005), making it more likely for adolescents to develop increases in depressive symptoms
over time. Thus, increases in body mass may affect depressive symptoms through the
stigma and social prejudices against these adolescents (Needham & Crosnoe, 2005).
These associations may be stronger for females than for males. Compared to boys,
girls are stigmatized significantly more often for their body mass, and they face more
teasing, bullying and marginalization in social relationships (Tang-Peronard, &
Heitmann, 2008).

2.1.1.3

Neurobiological causal pathways

In addition to social and psychological influences, physical health pathways exist
that may also explain the association between increases in body mass and increases in
depressive symptoms over time. For example, one such pathway is inflammation.
Increases in body mass can be regarded as an inflammatory state since weight gain has
been shown to activate inflammatory pathways (Emery, Fondow, Schneider, et al., 2007;
Shoelson, Herrero, & Naaz, 2007). This inflammation, in turn, has been associated with
an increase in depressive symptoms (Bremmer, Beekman, Deeg, et al., 2008; Milaneschi,
Corsi, Pennix, et al., 2009; Vaccarino, Johnson, Sheps, et al., 2007). In extreme cases of
increased body mass, obesity may involve hypothalamic-pituitary-adrenal (HPA) axis
dysregulation (Pasquali, Vicennati, Cacciari, & Pagotto, 2006; Walker, 2001), which is
known to be associated with depressive symptoms (Belanoff, Kalehzan, Sund, Fleming
Ficek, & Schatzberg, 2001; Holsboer, 2000). Using yet another example, obesity may
lead to increases in depressive symptoms through the associated increased risk of
diabetes mellitus and increased insulin resistance (Lee, Lee, Ser, Chen, & Chen, 2008),
both of which may result in brain alterations (Huber, 2008) and increased risk for
depressive symptoms (Ajilore, Haroon, Kumaran, et al., 2007).

10

2.1.1.4

Functional impairment

Functional impairment may also explain the association between higher body
mass and depressive symptoms. Individuals with a high body mass who have greater
difficulties with mobility and physical activity may be more likely to experience
depressive symptoms over time (Bornstein, Schuppenies, Wong, & Licinio, 2006; Lago,
Dieguez, Gomez-Reino, & Gualillo, 2007). For example, prospective studies have found
an inverse association between physical activity and the development of depressive
symptoms (Brown, Ford, Burton, Marshall, & Dobson, 2005; Camacho, Roberts,
Lazarus, Kaplan, & Cohen, 1991; Farmer, Locke, Moscicki, et al., 1988; Lampinen,
Heikkinen, Ruoppila, 2000; Paffenbarger, Lee, & Leung, 1994; Strawbridge, Deleger,
Roberts, & Kaplan, 2002).

2.1.1.5

Summary

Overall, increases in body mass may affect depressive symptoms through many
causal pathways, including an internalization of biased attitudes, weight-teasing,
neurobiological causal pathways, and functional impairment. This prospective association
may be stronger for female youth compared to male youth because females place greater
importance on thinness as a popular ideal for feminine beauty (Wadden & Stunkard,
1987). Girls are also more likely than boys to ruminate about and internalize negative
feelings associated with their weight status (Fredrickson & Roberts, 1997). Finally,
weight-teasing is more likely to occur for adolescent girls than boys (Tang-Peronard, &
Heitmann, 2008). These factors may all translate to stronger prospective associations
between higher body mass and increases in depressive symptoms for females compared
to males.

2.1.2

Depressive symptoms affecting body mass
In addition to higher body mass affecting depressive symptoms over time,

depressive symptoms may also lead to changes in body mass across adolescence and
young adulthood. The causal pathways through which this prospective association may
be explained includes neurobiological causal pathways and affect regulation, and
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impaired sleep quality and physical inactivity. Each causal pathway will be explained in
greater detail below.

2.1.2.1

Neurobiological causal pathways and affect-regulation

Depressive symptoms may lead to increases in body mass through various
neurobiological causal pathways. For example, increased levels of cortisol are observed
during periods of stress and depression, which can in turn induce abdominal obesity
(Björntorp, 2001). Furthermore, serotonin dysregulation may characterize both
depressive symptoms as well as the risk for obesity, such that individuals with
disturbances in serotonin regulation may attempt to regulate their serotonin levels by
consuming an excessive amount of carbohydrate-rich foods rich (Wurtman, Wurtmen,
Mark, et al., 1985). Similarly, according to the affect-regulation model, individuals with
increased depressive symptoms may be more likely to intake food excessively as an
attempt to alleviate their negative affect (Liem et al., 2008). Coping mechanisms for
depressive symptoms may also include consuming substances, such as cigarettes
(Hooshmand, Willoughby, & Good, 2011), that are associated with weight gain
(Goodman & Whitaker, 2002), as well as unhealthy eating (Laitinen, Power, Ek, Sovio,
Järvelin, & 2002). In sum, these unhealthy behaviors may explain the association
between depressive symptoms and weight gain (Greenfield, Rehm, & Rogers, 2002).

2.1.2.2

Sleep quality and physical inactivity

Impaired sleep quality is another potential causal pathway, as poor sleep quality is
common in individuals with clinically significant depressive symptoms (Lauer, Wiegand,
& Krieg, 1992; Riemann, Berger, & Voderholzer, 2001), and inadequate sleep is a risk
factor for weight gain (Gangwisch, Malaspina, Boden-Albala, & Heymsfield, 2005).
Depressive symptoms are also associated with lethargy, social withdrawal, and physical
inactivity (Faith et al., 2011), and could therefore lead to weight gain; although, many
authors report that adjusting for physical activity did not change the positive associations
they initially found between depressive symptoms and body mass (Goodman &
Whitaker, 2002; Needham & Crosnoe, 2005).
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2.1.2.3

Summary

Overall, depressive symptoms may affect weight gain through a variety of causal
pathways, including neurobiological causal pathways and affect-regulation, and impaired
sleep quality and physical inactivity. In contrast to the sex differences for the prospective
associations between body mass and subsequent depressive symptoms, there is no
theoretical rationale that prospective associations between depressive symptoms and
subsequent increases in body mass may be stronger for females compared to males.

2.2 Longitudinal research on the association between body
mass and depressive symptoms
Given this understanding of the groups of theoretical models, the longitudinal
research assessing these associations will be examined next. The three main objectives of
this section are to: 1) present a summary of all studies that investigated this research
question; 2) highlight the conceptual, methodological, and analytical differences among
studies that may contribute to the disparity in the current state of literature; and 3)
identify the major limitations of previous research that will be addressed in the present
study.
Several exclusion criteria were applied when selecting studies to present in the
literature review. First, since population-based associations examining change are of
interest, the following literature review excludes clinical studies and studies that used
clinical samples. Second, since depressive symptoms are of primary interest in the current
study, the literature review excludes studies that used a diagnosis of depression. Third,
only longitudinal studies in which the same participants were followed for two or more
cycles of data collection will be examined, and studies that did not measure changing
levels in the outcome of interest will be excluded (although these studies, when
appropriate, are included in the Appendix, for more comprehensive coverage of the
literature). Finally, in order to fully capture research on adolescents and/or young adults,
the present literature review focuses solely on studies in which participants were younger
than 30 years of age at the first cycle of data collection and older than 12 years of age at
the last cycle of data collection (Rindfuss, 1991).
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The following section will be divided into several component sections. Studies
will first be organized into the direction of association they aimed to assess (i.e., body
mass affecting depressive symptoms, and vice versa). Studies within each direction of
association will be further organized into two subgroups: those that examined change
across two points, and those that examined change across more than two points by using
statistical techniques for longitudinal data (e.g., survival analysis, growth curve
modeling). Summaries of research studies will then be presented in order to highlight the
current disparities in the literature and provide reasoning, where possible, to explain these
disparities. Following this literature review and summary, an overall rationale and
objective for the direction of research in this area will be presented, as well as the
limitations of past research that have prevented valid conclusions to be drawn concerning
the direction of association between body mass and depressive symptoms. This section
will conclude with a proposed model for examining the direction of these associations
over time within the adolescent and young adult developmental periods.
Before describing studies, it is important to recognize that there have been vast
differences in how depressive symptoms have been operationalized and measured in
previous research. Depressive symptoms have been measured using a wide array of
symptom scales, including the Center for Epidemiological Studies- Depression Scale
(CESD-D; Radloff, 1977), the Children’s Depression Inventory (CDI; Kovacs & Beck,
1977), the Hopkins Symptom Checklist (HSCL; Derogatis, Lipman, Rickels, Uhlenhuth,
& Covi, 2007), the Mood and Feeling Questionnaire (MFQ; Angold, Costello, Messer, et
al., 1995), and Minnesota Multiphasic Inventory- Obvious Depression Scale (MMPIODS; Greene, 1991). In addition to the differences in scales used across studies, there
were also several different versions of the same scale used across studies. With respect to
the CES-D for example, different studies have utilized the CES-D-5 (Xie et al., 2010), the
CES-D-9 (Merten et al., 2008), the CES-D-10 (Ball, Burton, & Brown, 2009), and the
Modified CES-D-18 (Goodman & Whitaker, 2002).
In addition, while some studies measured depressive symptoms using a
continuous measure of the scale (Boutelle, Hannan, Fulkerson, Crow, & Stice, 2010;
Franko, Striegel-Moore, Thompson, Schreiber, & Daniels, 2005; Merten et al., 2008;
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Pine, Cohen, Brook, & Coplan, 1997; Stice, Presnell, Shaw, & Rohde, 2005; TanofskyKraff, Cohen, Yanovski, et al., 2006; Xie et al., 2010), others used cutoffs to identify
clinically significant depressive symptoms (Ball et al., 2009; Clark et al., 2007; Goodman
& Whitaker, 2002; Jansen, van de Looij-Jansen, de Wilde, & Brug, 2008; Rhew,
Richardson, Lymp, et al., 2008), or both (Anderson, Murray, Johnson, et al., 2011;
Barefoot, Heitmann, Helms, et al., 1998). All of these different operationalizations and
measurements of depressive symptoms will be included for the purposes of presenting a
comprehensive literature review, as well as to demonstrate the variability that currently
exists across studies.

2.2.1

Body mass affecting depressive symptoms
Several studies have investigated whether increases in body mass affect

subsequent depressive symptoms in adolescents and young adults. These studies are
summarized below, as well as presented in greater detail in the Appendix. Studies are
first organized into whether they measured change in depressive symptoms across two
time points or more than two time points, then further organized into whether they
reported a prospective association or not.

2.2.1.1

Measuring change in depressive symptoms across two
time points

The majority of studies have measured change across two time points to estimate
the effect of body mass on subsequent depressive symptoms, controlling for prior levels
of depressive symptoms and other covariates. The following four studies reported
significant associations. First, Anderson and colleagues examined these associations in a
cohort of adolescent females from public schools across the USA at two time points:
grades six and eight (Anderson et al., 2011). The authors operationalized clinically
significant depressive symptoms as a CES-D score of 24 and over, and categorized BMI
into obese and non-obese using the Center for Disease Control (CDC) reference guide.
The authors found a significant interaction between race and body mass, such that obesity
status predicted subsequent clinically significant depressive symptoms only for White
females. Associations were not significant for Hispanics, or for non-Hispanic Blacks. The
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authors reported consistent findings when they repeated their analyses with depressive
symptoms (using continuous CES-D scores) and body mass (using continuous BMI zscores).
Ball and colleagues examined these associations in a cohort of young women in
Australia who were 22-27 years old at baseline, and re-examined them three years later
(Ball et al., 2009). The authors operationalized clinically significant depressive symptoms
as a CES-D-10 score of 10 or more, and used the World Health Organization (WHO)
classifications to categorize BMI (i.e., into underweight, overweight, normal weight, and
obese categories). They found that overweight and obese females, compared with normal
weight females, had a greater risk for clinically significant depressive symptoms at
follow-up.
Using a nationally representative cohort from the United States, Merten and
colleagues (2008) examined whether adolescent obesity at baseline was associated with
increases in depressive symptoms six years later. The authors used continuous scores
from the CES-D-9 as a measure of depressive symptoms, and categorized BMI into obese
and not obese groups using the CDC reference guide. They reported a significant sex
interaction, such that obesity for female adolescents, but not for male adolescents, was
associated with higher depressive symptoms in young adulthood.
Xie and colleagues (2010) used multiple group structural equation models to
compare associations of obese status on subsequent depressive symptoms in a community
sample of Asian and Hispanic middle school students in Los Angeles followed over one
year. The authors used continuous scores from the CES-D-5 as a measure of depressive
symptoms, and categorized BMI into overweight and not overweight groups using the
CDC reference guide. They examined associations separately for males and females, for
Asians and Hispanics, and for accultured and not accultured adolescents. They found that
Asian males who were overweight at baseline had higher depressive symptoms at followup than non-overweight Asian males. Also, males with low acculturation who were
overweight at baseline had higher subsequent depressive symptoms compared to their not
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overweight counterparts. The authors did not find any other significant associations (i.e.,
for girls, high accultured boys, or Hispanic boys).
Only three studies that measured change in depressive symptoms across two time
points did not report any significant findings. First, Clark and colleagues (2006)
examined associations in a representative sample of adolescents (ages 11-14; reexamined two years later) attending schools in East London. The authors identified
clinically significant depressive symptoms as a score of eight or higher, using the Short
Mood and Feeling Questionnaire (SMFQ; Angold et al., 1995), and used the United
Kingdom reference curve classifications to categorize BMI into overweight (i.e., having a
BMI greater than the 85th percentile), and obese (i.e., having a BMI greater than the 95th
percentile). They found that neither overweight nor obese status predicted subsequent
clinically significant depressive symptoms.
Using a nationally representative cohort of US adolescents, Goodman and
Whitaker (2002) examined the association between obesity in 7th-12th grade adolescents
and clinically significant depressive symptoms one year later. The authors categorized
clinically significant depressive symptoms as a Modified CES-D-18 score of 24 or more
for females, and 22 or more for males, and used the CDC reference classifications for
classifying BMI into obese and not obese categories. They found that being obese at
baseline did not predict clinically significant depressive symptoms at follow-up.
Rhew and colleagues examined whether overweight status in sixth grade
predicted depressive symptoms one year later in a cohort of middle school students in
Seattle, Washington (Rhew et al., 2008). The authors examined continuous logtransformed depressive symptoms, measured using the MFQ (Angold et al., 1995), and
categorized BMI into obese, overweight, and not overweight groups using CDC reference
guides. They found that neither overweight nor obese status at baseline predicted
depressive symptom scores at follow-up.

17

2.2.1.2

Measuring change in depressive symptoms using more
than two time points

Only one study used more complex longitudinal analyses in order to examine
changes across more than two time points. Using repeated measures multivariate logistic
regression over four annual cycles of data, Boutelle and colleagues examined the
influence of overweight or obesity status the previous year on depressive symptoms the
subsequent year, in adolescent females from public and private schools in Austin, Texas
(Boutelle et al., 2010). The authors examined continuous depressive symptoms using an
average of past year severity ratings for each symptom in the Schedule for Affective
Disorders and Schizophrenia for School-Age Children (K-SADS; Chambers, PuigAntich, Hirsch, et al., 1985). Response options for each symptom ranged from 1 (not at
all) to 4 (severe). BMI was categorized into obese, overweight, and not overweight
groups using CDC reference guides. The authors reported a significant positive effect of
obesity (but not overweight) on subsequent depressive symptoms.

2.2.1.3

Summary of studies examining body mass affecting
depressive symptoms

In summary, these studies all aimed to investigate the theoretical framework that
body mass leads to increases in depressive symptoms through the previously mentioned
causal pathways (i.e., internalization of biased attitudes, weight-teasing, neurobiological
causal pathways, and functional impairment). Of the eight studies reviewed, almost half
did not report finding any sort of an association between baseline body mass and
subsequent depressive symptoms. This discrepancy in research findings highlights the
high level of inconsistency in research. One explanation for this inconsistency may be
that inconsistent findings reflect an inconsistent phenomenon- that is, that body mass may
predict depressive symptoms for some individuals but not others (Friedman & Brownell,
1995). Although this may be the case, it is difficult to make this conclusion because the
high level of variation among current studies makes cross-study comparisons
challenging.
These variations occur at the conceptual, methodological, and analytical levels,
and may explain a great deal of the disparity in results for studies investigating body
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mass as a predictor of subsequent depressive symptoms. Conceptual differences across
studies exist in terms of the developmental periods studied, the operationalization of body
mass and body mass comparison groups, the operationalization of depressive symptoms,
and differences in the populations studied.
With respect to the first conceptual variation, the majority of studies did not
examine the developmental transition from adolescence to young adulthood, but instead
focused solely on changes within adolescence (Anderson et al., 2011; Boutelle et al.,
2010; Clark et al., 2007; Rhew et al., 2008; Xie et al., 2010), or young adulthood (Ball et
al., 2009). Although all studies operationalized body mass using categorizations, one
study used a continuous measure of BMI in addition to categorization (Anderson et al.,
2011).
There were also large variations among studies in operationalizing body mass
comparison groups. For example, some studies compared obese adolescents to not obese
adolescents, where the not obese group included individuals classified as overweight,
normal weight, or underweight (Anderson et al., 2011; Goodman & Whitaker, 2002;
Merten et al., 2008). Other studies compared obese and/or overweight groups to not
overweight groups, where the not overweight group included individuals classified as
either normal weight or underweight (Boutelle et al., 2010; Clark et al., 2007; Rhew et
al., 2008; Xie et al., 2010). Of note, only one study compared obese, overweight, and
underweight groups separately with normal weight groups (Ball et al., 2009).
As previously mentioned, some studies operationalized depressive symptoms into
categories by establishing clinically significant cutoffs from scaled continuous measures
(Ball et al., 2009; Clark et al., 2007; Goodman & Whitaker, 2002). Other studies,
however, operationalized depressive symptoms as a continuous scale, with higher scores
indicating more depressive symptoms (Boutelle et al., 2010; Merten et al., 2008; Rhew et
al., 2008; Xie et al., 2010). One study used both a continuous and categorized
operationalization of depressive symptoms (Anderson et al., 2011).
Studies also differed in the composition of the populations they examined. While
most studies sampled both males and females (Clark et al., 2007; Goodman & Whitaker,
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2002; Merten et al., 2008; Rhew et al., 2008; Xie et al., 2010), some sampled females
only (Anderson et al., 2011; Ball et al., 2009; Boutelle et al., 2010). Also, some studies
used at-risk samples (Rhew et al., 2008), samples with one predominant race/ethnicity
(Xie et al., 2010), or samples from outside of North America (Ball et al., 2009; Clark et
al., 2007).
Methodologically, there are large variations among the length of intervals, source
of height and weight measurements, reference tools for establishing body mass cutoffs,
and tools for measuring depressive symptoms. In particular, studies differed on whether
they examined associations over annual (Boutelle et al., 2010; Goodman et al., 2002;
Rhew et al., 2008; Xie et al., 2010), biennial (Anderson et al., 2011; Clark et al., 2007),
or longer (Ball et al., 2009; Merten et al., 2008) intervals. Additionally, when calculating
BMI, some studies used measured height and weight (Anderson et al., 2011; Boutelle et
al., 2010; Clark et al., 2007; Xie et al., 2010), while others used self-reported height and
weight (Ball et al., 2009; Goodman & Whitaker, 2002; Merten et al., 2008).
With regards to reference tools for establishing body mass cutoffs, studies ranged
in their use of categorizations based on CDC (Anderson et al., 2011; Boutelle et al., 2010;
Goodman & Whitaker, 2002; Merten et al., 2008; Rhew et al., 2008; Xie et al., 2010),
WHO (Ball et al., 2009), or other reference guides (Clark et al., 2007). Finally, every
study used a slightly different measurement tool to assess depressive symptoms, ranging
from K-SADS (Boutelle et al., 2010), MFQ (Rhew et al., 2008) or SMFQ (Clark et al.,
2007), and different versions of the CES-D (Anderson et al., 2011; Ball et al., 2009;
Merten et al., 2008; Goodman & Whitaker, 2002; Xie et al., 2010).
Analytically, studies varied in the number of measurement points used for
analyses. While one study examined associations over three or more cycles (Boutelle et
al., 2010), the majority of research in this area focused on assessing only two points
(Anderson et al., 2011; Ball et al., 2009; Clark et al., 2007; Goodman & Whitaker, 2002;
Merten et al., 2008; Rhew et al., 2008; Xie et al., 2010). Studies also varied in the
statistical techniques they used to assess whether body mass predicted subsequent
depressive symptoms, with some using logistic regression techniques (Ball et al., 2009;
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Clark et al., 2007; Goodman & Whitaker, 2002), and others using linear regression
techniques (Boutelle et al., 2010; Merten et al., 2008; Rhew et al., 2008; Xie et al., 2010).
Finally, there have been large discrepancies between each study with respect to
the covariates controlled for during analyses. The table in the Appendix illustrates this
discrepancy by listing all covariates considered for each study. Entering a different set of
covariates into a model could impact results by changing the estimated effect that body
mass has on subsequent depressive symptoms. Without this consistency in covariates
used, cross-study comparisons are made much more difficult.
Certain patterns are evident with respect to these conceptual, methodological, and
analytical variations among studies, in which certain types of studies may be more likely
to report an effect than others. Restricting the literature review to only those two studies
that examined, to some extent, the transition between adolescence and young adulthood,
both studies investigated associations in both males and females, and reported
nonsignificant associations for males (Goodman & Whitaker, 2002; Merten et al., 2008).
When focusing on adolescents as they transition to young adulthood, there is
some evidence that body mass may be more predictive of moderate increases in
depressive symptoms, as opposed to being predictive of clinically significant depressive
symptoms. For example, Goodman and Whitaker (2002) used a CES-D cutoff for
predicting clinically significant depressive symptoms in adolescents (Roberts et al.,
1991), and reported that 12-19 year-olds who were obese at baseline did not have an
increased risk of clinically significant depressive symptoms when measured one year
later. On the other hand, using a continuous scale for depressive symptoms, Merten and
colleagues (2008) examined the association between obesity at age 12-18 and depressive
symptoms five years later and found that, among females, obesity in adolescence was
associated with higher depressive symptom scores during young adulthood.
From these patterns, there is some evidence that, for adolescents transitioning to
young adulthood, associations between body mass and subsequent depressive symptoms
are nonsignificant for males; and also that increases in body mass may lead to higher
levels of depressive symptoms, but not necessarily clinically significant depressive
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symptoms. However, it is still difficult to compare findings across studies with two or
even three similarities, as results may be confounded by the many other study differences
(i.e., operationalization of body mass comparison groups, populations examined,
statistical techniques, and covariates modelled). Overall, although greater precision in
conceptualization, methodology, and analytical techniques across studies would
potentially translate to less variety in results, the vast differences in the design of
previous studies makes cross-study comparisons difficult.

2.2.2

Depressive symptoms affecting body mass
Several studies have also investigated whether depressive symptoms affect

subsequent increases in body weight in adolescents and young adults. These studies are
summarized below, as well as presented in greater detail in the Appendix. Studies are
first organized into whether they measured change in body mass across two time points
or more than two time points, then further organized into whether they reported a
prospective association or not.

2.2.2.1

Measuring change in body mass with only two time points

Several studies have measured change across two time points in order to estimate
the influence of depressive symptoms on subsequent body mass, controlling for prior
levels of body mass and other covariates. The following five studies reported significant
associations. First, Anderson and colleagues (2011) examined these associations in a
cohort of adolescent females from public schools across the USA at two time points:
grades six and eight. The authors operationalized clinically significant depressive
symptoms as a CES-D score of 24 and over, and categorized BMI into obese and nonobese using the Center for Disease Control (CDC) reference guide. The authors found a
significant interaction between depressive symptoms and race such that, having clinically
significant depressive symptoms at sixth grade predicted subsequent obesity in White
females, but not in Black or Hispanic females. They also repeated their analyses using
continuous BMI scores and continuous depressive symptom scores and found similar
results.

22

Using a nationally representative cohort of USA adolescents, Goodman and
Whitaker (2002) examined the association between clinically significant depressive
symptoms in 7th-12th grade adolescents and obesity one year later. The authors
categorized clinically significant depressive symptoms as a Modified CES-D-18 score of
24 or more for females, and 22 or more for males, and used the CDC reference
classifications for classifying BMI into obese and not obese categories. The authors
found that those who had clinically significant depressive symptoms at baseline had a
higher risk of obesity at follow-up, compared to those who did not have clinically
significant depressive symptoms at baseline.
Franko et al. (2005) used two community-based cohorts of Black and White
females from three US states to examine the influence of depressive symptoms (using
continuous CES-D scores) on subsequent body mass. Body mass was analyzed as both a
continuous and categorical variable (i.e., categorized into obese and not obese categories,
using CDC reference guidelines). The first cohort was examined at age 16 and again at
age 21; the second cohort was examined at age 18 and again at age 21. The authors
reported that higher depressive symptoms at either age 16 or 18 predicted an increased
risk of obesity at age 21. They also found a similar pattern of results when body mass was
examined as a continuous variable, such that higher depressive symptoms at either age 16
or 18 predicted an increase in body mass at age 21.
Barefoot and colleagues examined associations between depressive symptoms and
body mass in a cohort of North Carolina university students aged 16-25 at baseline, and
again 23 years later (1998). Depressive symptoms were analyzed as both a continuous
and categorical variable. As a categorical variable, the authors defined a high level of
depressive symptoms as a Minnesota Multiphasic Inventory- Obvious Depression Scale
(MMPI-ODS; Greene, 1991) score of 11 or higher for males, and 13 or higher for
2

females . The authors found a significant interaction between initial body mass and

2

Note, the categorization of high level of depressive symptoms identified by the authors does not reflect a
level of clinically significant depressive symptoms, but only identifies those with a relatively large number
of depressive symptoms (Barefoot et al., 1998).
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depressive symptoms on weight change, such that individuals with a high level of
depressive symptoms who were initially lean gained less weight (i.e., less of a change in
BMI between two time points) than individuals with a low level of depressive symptoms
who were initially lean. Furthermore, individuals with a high level of depressive
symptoms who were initially heavy gained more weight than individuals without a high
level of depressive symptoms. The authors reported similar results when a continuous
measure of depressive symptoms was used instead of a dichotomized cutoff.
Fifth, Rhew et al., 2008 examined whether clinically significant depressive
symptoms in sixth grade predicted body mass one year later in a cohort of middle school
students in Seattle, Washington. The authors categorized clinically significant depressive
symptoms as a MFQ score of 15 or higher for males, and 20 or higher for females, and
used a continuous measure of self-reported BMI. They found a significant interaction
between sex and depressive symptoms. Males with clinically significant depressive
symptoms at baseline had lower subsequent body mass compared to males without
clinically significant depressive symptoms. For females, clinically significant depressive
symptoms at baseline did not predict subsequent body mass.
Two studies that measured change in body mass across two time points did not
report any significant findings. First, Stice et al. (2005) examined associations between
depressive symptoms at 11-15 years and development of obesity over a four-year period
in a sample of adolescent girls from schools across metropolitan southwestern USA. The
authors examined continuous depressive symptoms using an average of severity ratings
for each symptom in the K-SADS. BMI was categorized into obese and not obese groups
using CDC reference guides. The authors found that depressive symptoms at baseline did
not predict the onset of obesity over a four-year period.
In another study, Jansen et al. (2008) examined associations between clinically
significant depressive symptoms and subsequent overweight and obesity (using WHO
classifications) in a cohort of youth from Rotterdam, ages 9-10 at baseline and 12-13 at
follow-up. The authors categorized clinically significant depressive symptoms as a score
of four or more using the Short Depression Questionnaire for Children (SDQC; Meier,
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Mellenbergh, & de Wit, 1986), and used WHO classifications for categorizing BMI into
not overweight, overweight, and obese categories. The authors found that clinically
significant depressive symptoms at baseline did not predict overweight status or obese
status three years later in this cohort of young adolescents.

2.2.2.2

Measuring change in body mass using more than two time
points

Only one study testing the directional association between baseline depressive
symptoms and subsequent body mass used more than two time points. Tanofsky-Kraff et
al. (2006) used an average of 4.2 annual measurements of children from Maryland, USA,
who were 6-12 years old at baseline, and applied mixed regression models with
depressive symptoms as a fixed effect and the child as a random effect. The authors used
CDI scores as a continuous measure of depressive symptoms, and used a dual-energy xray absorptiometry (DEXA) continuous scale to measure fat mass and change in fat mass
over time. The authors found that baseline depressive symptoms did not predict increases
in body fat mass over the course of the study, and that interaction effects with sex were
not statistically significant.

2.2.2.3

Summary of studies examining depressive symptoms
affecting body mass

In summary, although all of these studies investigated the theoretical framework
that depressive symptoms lead to increases in body mass through the previously
mentioned causal pathways (i.e., neurobiological causal pathways and affect-regulation,
and sleep quality and physical inactivity), most did not make any explicit mention of a
driving theoretical framework (Barefoot et al., 1998; Franko et al., 2005; Goodman &
Whitaker, 2002; Jansen et al., 2008; Rhew et al., 2008; Tanofsky-Kraff et al., 2006;).
Overall, there is some evidence that initial depressive symptoms are prospectively
associated with an increase in body mass in adolescents and young adults. On the other
hand, almost one half of the studies testing the directional association from depressive
symptoms to body mass reported null findings. There was also a great deal of
inconsistency regarding whether or not differential prospective associations between
depressive symptoms and subsequent body mass exist for males and females. Of the five
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studies that assessed sex differences, only one found a different pattern of results for
males and females such that associations were inversely significant for males (i.e.,
clinically significant depressive symptoms predicted lower subsequent BMI; Rhew et al.,
2008).
As was the case above, the inconsistencies in results of studies assessing the
direction of association from depressive symptoms to increases in body mass reflect a
disparity in the conceptual, methodological, and analytical frameworks among studies.
Conceptual differences across studies examining whether depressive symptoms predict
increases in body mass are similar to those studies examining the opposite direction of
association (i.e., body mass to depressive symptoms). Differences across studies exist on
multiple levels in terms of developmental periods studied, operationalization of body
mass, and differences in the populations studied.
Only two studies examined the developmental transition from adolescence to
young adulthood (Franko et al., 2005; Goodman & Whitaker, 2002). Instead, most
studies focused solely on changes within adolescence (Anderson et al., 2011; Jansen et
al., 2008; Rhew et al., 2008; Stice et al., 2005; Tanofsky-Kraff et al., 2006); or young
adulthood (Barefoot et al., 1998).
With regards to operationalizing body mass into categories, most studies used
cutoffs to define overweight and/or obese status (Goodman & Whitaker, 2002; Jansen et
al., 2008; Rhew et al., 2008; Stice et al., 2005). A few studies, however, operationalized
body mass as a continuous scale of BMI (Barefoot et al., 1998; Tanofsky-Kraff et al.,
2006). One study used both a continuous and categorized operationalization of body mass
(Anderson et al., 2011).
Studies also differed in the populations they examined. While most studies
sampled both males and females (Barefoot et al., 1998; Goodman & Whitaker, 2002;
Jansen et al., 2008; Rhew et al., 2008; Tanofsky-Kraff et al., 2006), some sampled
females only (Anderson et al., 2011; Franko et al., 2005; Stice et al., 2005). There were
also some differences across studies in the composition of the population from which
participants were sampled. For example, a few studies used at-risk samples (Rhew et al.,
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2008; Tanofsky-Kraff et al., 2006). Anderson and collegues (2011), as well as Goodman
and Whitaker (2002) included only Hispanic, non-Hispanic Black, and non-Hispanic
White adolescents in their studies. Franko and colleagues (2005), and Tanofsky-Kraff et
al., (2006) only sampled Black or White participants from the United States. One study
investigated associations in adolescents and young adults from the Netherlands (Jansen et
al., 2008).
Methodologically, there are large variations among the length of intervals, source
of height and weight measurements, reference tools for establishing body mass cutoffs,
and tools for measuring depressive symptoms. In terms of interval length, most studies
examined associations over annual (Goodman & Whitaker, 2002; Rhew et al., 2008;
Stice et al., 2005; Tanofsky-Kraff et al., 2006) or biennial (Anderson et al., 2011; Franko
et al., 2005) cycles, whereas others used intervals between three and six years (Franko et
al., 2005; Jansen et al., 2008) or much longer (Barefoot et al., 1998).
When calculating BMI, most studies used measured height and weight (Anderson
et al., 2011; Stice et al., 2005), while one used self-reported height and weight (Goodman
& Whitaker, 2002). Of note, a few studies used inconsistent measurements between
cycles (Barefoot et al., 1998; Franko et al., 2005; Jansen et al., 2008). That is, height and
weight would be measured at one cycle and self-reported at another. One study used
DEXA to directly measure fat mass (Tanofsky-Kraff et al., 2006). With regards to
reference tools for establishing body mass cutoffs, almost all but one study (Jansen et al.,
2008) used categorizations based on CDC.
Finally, almost every study used a slightly different measurement tool to assess
depressive symptoms, including K-SADS (Stice et al., 2005), MFQ (Rhew et al., 2008),
MMPI ODS (Barefoot et al., 1998), CDI (Tanofsky-Kraff et al., 2006), SDQC (Jansen et
al., 2008), and different versions of the CES-D (Anderson et al., 2011; Franko et al.,
2005; Goodman & Whitaker, 2002).
Analytically, studies varied in the number of measurement points used for
analyses. While one study examined associations over four cycles (Tanofsky-Kraff et al.,
2006), the majority of research in this area focused on assessing only two points
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(Anderson et al., 2011; Franko et al., 2005; Goodman & Whitaker, 2002; Jansen et al.,
2008; Rhew et al., 2008; Stice et al., 2005). Studies also varied in the statistical
techniques they used to assess whether depressive symptoms predicted subsequent body
mass, with some using logistic regression techniques (Goodman et al., 2002; Jansen et al.,
2008; Stice et al., 2005), and others using linear regression techniques (Barefoot et al.,
1998; Rhew et al., 2008; Tanofsky-Kraff et al., 2006).
As was the case for studies examining the effect of body mass on subsequent
depressive symptoms, studies examining this direction of association have also varied
greatly in their use of covariates controlled for during analyses. The table in the
Appendix illustrates this discrepancy by listing all covariates considered for each study.
As mentioned above, inconsistencies in covariates used make cross-study comparisons
much more difficult.
Overall, there are potentially multiple combinations of differences across studies
with respect to the operationalization of depressive symptoms and body mass, the
populations studied, the number and length of intervals, the statistical technique for
analyses, and the use of covariates that could drastically affect not only the findings of
each study, but also the interpretation of the literature. For example, continuous BMI
levels may be differentially associated with depressive symptoms than an obesity or
overweight classification. Similarly, continuous depressive symptoms may predict body
mass differentially than clinically significant depressive symptoms. Furthermore,
differences in results may exist between males and females, across different races, or
across samples selected from different parts of the world. Finally, entering a different set
of covariates into a model could impact results by changing the estimated effect that
depressive symptoms have on subsequent body mass. Overall, the multiple possibilities
of study design makes comparisons difficult because it becomes impossible to tease out
similarities among studies when there are yet so many levels of differences.
As opposed to the findings from studies investigating the direction of association
from body mass to depressive symptoms, previous research examining the direction of
association from depressive symptoms to body mass had few discernable patterns in
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results with regards to conceptual, methodological, and analytical differences. That is,
because there were such few similarities and such great differences among studies, it was
not possible to identify certain types of studies that were more likely to find an effect than
others. One evident pattern was that, of the two studies that examined both males and
females and did not report a significant effect (Jansen et al., 2008; Tanofsky-Kraff et al.,
2006), both controlled for sex in the analysis instead of testing whether results differed
for males and females. Rhew and colleagues (2008) found that males clinically
significant depressive symptoms at baseline had lower subsequent body mass, whereas
females with clinically significant depressive symptoms at baseline had higher
subsequent body mass. Thus, not accounting for this sex difference analytically may lead
to null associations.
Overall, there is some evidence that with respect to depressive symptoms
predicting body mass, differential associations may exist between males and females.
However, because of the complexity and amount of conceptual, methodological, and
analytical differences among studies, it is difficult to conclusively compare findings. As
previously mentioned, greater precision in the methodologies across studies would
translate to less variety in results. However, the vast differences in the current state of
literature on depressive symptoms predicting body mass make cross-study comparisons
difficult. A major goal for research in this area should be to work towards greater
consistency by addressing the major limitations of previous research and providing a
strong justification for the operationalization of concepts, as well as the methodologies
and analytical techniques used.

2.2.3

Limitations in current literature
In addition to the above-mentioned conceptual, methodological, and analytical

differences among studies, there are several key within-study limitations that may also
contribute to mixed findings in the literature. The major limitations of previous research
are: lack of consistency in measuring body mass and depressive symptoms over cycles,
failure to assess longitudinal change in outcomes, using only two waves of data, failure to
examine reciprocal relationships, and finally, lack of transitional research examining the
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adolescent to young adult developmental period. Problems with these key limitations are
explained in detail below. These within-study limitations are also summarized in Table 1.
Table 1: Within-study limitations of previous research.
First author, year

Anderson, 2011
Ball, 2008
Bardone, 1998*
Barefoot, 1998
Boutelle, 2010
Clark, 2006
Duarte, 2010*
Franko, 2005
Goodman, 2002
Goodwin, 2009*
Herva, 2006*
Jansen, 2008
Merten, 2008
Pine, 1997*
Rhew, 2008
Stice, 2005
Tanofsky-Kraff,
2006
Xie, 2010

Inconsistent
measurement
tool for body
mass and/or
depressive
symptoms

Did not
control for
or exclude
baseline
dependent
variable

X
X

X
X
X
X
X
X

X

Two
cycles

Did not
examine
reciprocal
relationship

X
X
X
X
X
X
X
X
X
X
X
X
X
X

X
X
X
X
X
X
X
X
X
X
X
X

Did not
examine
adolescent
to young
adult
transition

X
X
X
X
X

X

X
X

X

Note. *Not included in literature review because does not measure
change in outcome.

X
X

X
X
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2.2.3.1

Inconsistency in measurement tools for body mass and/or
depressive symptoms

Many studies have used inconsistencies in the source of height and weight reports
across cycles (Barefoot al., 1998; Franko et al., 2005; Jansen et al., 2008). For example,
Franko and colleagues (2005) used self-reported height and weight to calculate
participants BMI at the first cycle, but used measured height and weight during the
subsequent cycle. Similarly, Jansen and colleagues (2008) and Barefoot and colleagues
(1998) both used measured height and weight at baseline and self-reported height and
weight at follow-up. Inconsistencies across cycles in the source of height and weight
reports may bias results if sources are differentially accurate in their reports of height and
weight (Goodman, Hinden, & Khandelwal, 2000).
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2.2.3.2

Failure to assess longitudinal change in outcomes

Many studies did not assess longitudinal change in outcomes because they failed
to control for baseline levels of the dependent variable (Bardone, Moffitt, Caspi, et al.,
1998; Duarte, Sourander, Nikolakaros, et al., 2010; Goodwin, Sourander, Duarte, et al.,
2009; Herva, Laitinen, Miettunen, et al., 2006; Pine et al., 1997). As is the case with all
longitudinal analyses, controlling for initial levels of an outcome ensures that models are
predicting change over time instead of stability in the health outcome over time (Stice &
Bearman, 2001). For example, past depressive symptoms are known to predict future
depressive symptoms (Eaton, Shao, Nestadt et al., 2008), thus, failing to control for initial
levels of depressive symptoms makes it difficult to model the effects of body mass on the
development of depressive symptoms.

2.2.3.3

Examining less than three cycles of data

The third major limitation of previous research is that most studies measured
these health outcomes across only two waves (Anderson et al., 2011; Ball et al., 2009;
Barefoot et al., 1998; Clark et al., 2007; Franko et al., 2005; Goodman & Whitaker, 2002;
Jansen et al., 2008; Merten et al., 2008; Rhew et al., 2008; Xie, et al., 2010). Although
technically measuring change, these studies assess development poorly (Rogosa, Brandt,
& Zimowski, 1982) because two-panel designs do not allow for examination of
developmental trajectories, and thus may only be appropriate when the growth process is
irrelevant or known to be linear (Duncan, Duncan, & Strycker, 2006). However, neither
body mass nor depressive symptoms are linear processes during the transition between
adolescence and young adulthood (Needham et al., 2010). Thus, measuring less than
three waves of data does not take into account the growth process involved nor does it
allow for the identification of curvilinear trajectories for either health outcome.

2.2.3.4

Failure to examine reciprocal relationship

The majority of longitudinal studies (Ball et al., 2009; Barefoot et al., 1998;
Boutelle et al., 2010; Clark et al., 2007; Franko et al., 2005; Jansen et al., 2008; Merten et
al., 2008; Stice et al., 2005; Tanofsky-Kraff et al., 2006; Xie et al., 2010) that test the
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association between body mass and depressive symptoms have focused on measuring
only one direction of the relationship (i.e., body mass predicting depressive symptoms, or
vice versa). Statistically measuring one direction does not test whether there are
reciprocal associations between body mass and depressive symptoms within the same
sample. Investigating reciprocal relationships over time is important in order to examine
whether the predictive relationship is unidirectional, or whether there are reciprocal
effects where either construct may predict growth in the other (Needham, et al., 2010).
These alternative mechanisms would have different implications for etiology, prevention,
and treatment.

2.2.3.5

Lack of adolescent to young adulthood transitional
research

Finally, many studies focus on young adult populations (Ball et al., 2009;
Barefoot et al., 1998; Forman-Hoffman et al., 2007; McCarty, Kosterman, Mason, et al.,
2009; Needham et al., 2010; Roberts et al., 2003) or younger adolescents (Anderson et
al., 2011; Boutelle et al., 2010; Clark et al. 2007; Jansen et al., 2008; Rhew et al., 2008;
Tanofsky-Kraff et al., 2006; Xie et al., 2010). The association between body mass and
depressive symptoms may be different for adolescents than for children or adults
(Napolitano & Foster, 2008), and there is far less research on adolescents as they
transition into young adults. Adolescence and young adulthood are critical periods of
growth and maturation, and are associated with changes in diet, physical activity,
sedentary behavior, as well as psychological health (Alberga, Sigal, Goldfield,
Prud'homme, & Kenny, 2012). Thus, an understanding of the causal associations between
mental and physical health during this transition is needed, and differentiating findings
from earlier or later life stages is important for public health initiatives.
Only four studies in the present literature review examined prospective
associations as adolescent’s transition into young adults (Franko et al., 2005; Goodman &
Whitaker, 2002; Merten et al., 2008; Stice et al, 2005). However, each of these studies
present with limitations of their own, as identified in Table 1. For example, by only
examining two data points, Merten and colleagues (2008) could not effectively examine
the developmental growth in either health outcome. Also, having a six-year interval
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between data points could potentially increase the chances of transitional life events
confounding prospective associations. The second major limitation of the Merten and
colleagues (2008) study is that they compared obese adolescents to not obese adolescents,
such that the not obese group comprised of overweight, normal weight, or underweight
adolescents. The mental health status of overweight and underweight adolescents may be
systematically different from normal weight adolescents, and collapsing all three weight
categories into a single comparison group may bias results if there are differences among
these weight categories.
In another example, the study by Franko and colleagues (2005) is limited in its
ability to generalize to the population since the authors only sampled Black and White
females. They also had inconsistent reporting sources for height and weight, where selfreports were used at the first wave and measured height and weight at the second wave.
Therefore, the increase in body mass at the second wave may reflect a true consistency in
body mass that was not captured in the first wave because adolescents tend to underestimate their weight and over-estimate their height, thus lowering their initial BMI
(Danubio, Miranda, Vinciguera, Vecchi, & Rufo, 2008; Elgar, Roberts, Moore, & TudorSmith, 2005; Must & Strauss, 1999). Overall, among the very few studies that did
examine the developmental transition from adolescence to young adulthood,
inconsistencies in findings are evident among studies, and major methodological flaws
exist within each study.

2.2.4

Summary of literature review
In summary, there are several conceptual, methodological, and analytical

differences that exist in the present state of the literature. Despite many studies having
examined this research question, the level and complexity of variation among existing
research makes cross-study comparisons difficult, thus complicating interpretability of
findings. These inconsistencies among studies combine with the various abovementioned limitations within studies. These include: lack of consistency in measuring
body mass and depressive symptoms, failure to assess longitudinal change in outcomes,
using only two waves of data, failure to examine reciprocal relationships, and a lack of
transitional research between adolescence and young adulthood. Taken together, as the
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literature currently stands, it is difficult to draw concrete conclusions about the
prospective associations between body mass and depressive symptoms across
adolescence and young adulthood. With these limitations in mind, the next section will
highlight the rationale for this study, as well as its objectives and hypotheses.

2.3 Plan of study, objectives, and hypotheses
The purpose of the present study is to assess the association between two
developmental processes, body mass and depressive symptoms, as adolescent’s transition
into young adulthood. As can be deduced by the literature review presented above,
several studies have already examined this research question. However, this study was
conducted in order to address the major limitations and gaps of previous research in this
area, as well as to contribute to some level of consistency that will help make cross-study
comparisons possible in the future. Thus, strong conceptual, methodological, and
analytical justifications were made throughout the following methods section.
The specific objectives of this study are to: 1) examine individual trajectories of
body mass and depressive symptoms as adolescents transition into young adulthood; 2)
examine if changes in body mass over time are associated with changes in depressive
symptoms over time; 3) examine whether initial levels of body mass predict changes in
depressive symptoms over time, and/or vice versa; and 4) examine whether any of the
above associations differ between sex.
For objective (1), based on previous research (Ge et al., 2006; Kuczmarski et al.,
2002; Needham et al., 2010), we expect to find an increase in body mass over time and a
decrease in depressive symptoms over time. Additionally, we expected to see body mass
levels to be consistently higher for males than females (Shields, 2006), and depressive
symptom levels to be consistently higher for females than males (Kuczmarski et al.,
2002; Locke & Newcomb, 2001), at all time points.
Given that there is little research examining the association between changes in
both health constructs over time, and the inconsistencies in the literature on the direction
and strength of this association for males and females, objectives (2), (3), and (4) were
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examined in a purely exploratory manner. However, we expect that, if a prospective
association is evident between initial body mass and subsequent growth in depressive
symptoms, it would be stronger for females than males. This hypothesis is made on the
grounds of both the theoretical and empirical evidence presented in the literature review.
As previously stated, weight concerns (Fredrickson & Roberts, 1997; Wadden &
Stunkard, 1987), a greater level of weight-related stigmatization (Tang-Peronard, &
Heitmann, 2008), and weight-teasing (Eisenberg et al., 2006; Tang-Peronard, &
Heitmann, 2008) are more common in adolescent females than males. Furthermore, in
both longitudinal studies that examined body mass affecting depressive symptoms during
the transition between adolescence and young adulthood, associations for males were
consistently nonsignificant across both studies (Goodman & Whitaker, 2002; Merten et
al., 2008).
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Chapter 3

3

Methods

3.1 Data
3.1.1

Data source
This study is based on a secondary data analysis of the National Longitudinal

Survey of Children and Youth (NLSCY; Statistics Canada, 2009). The NLSCY is a
population-based longitudinal study of Canadian children that follows their development
and well-being from birth to early adulthood. The NLSCY was collected as a joint project
of Human Resources Development Canada and Statistics Canada, and is designed to
evaluate the determinants of developmental outcomes in Canadian children. The
objectives of the survey include determining the prevalence of various risk and protective
factors, understanding how factors and life events influence development, and collecting
biological, social, and environmental information about children as they grow (Statistics
Canada, 2009).

3.1.2

Sampling design and data collection
The target population for the original cohort in cycle 1 was selected from the

Statistics Canada Labour Force Survey (LFS) and the National Population Health Survey
(NPHS). The LFS is a monthly survey that collects labour market data from a national
sample. It is representative of the civilian, non-institutionalized population aged 15 or
over in Canada’s 10 provinces. The LFS excludes residents of Yukon, Nunavut, and the
Northwest Territories, as well as people living on Indian reserves, full-time members of
the Canadian Armed Forces, and inmates of institutions; thus excluding approximately
2% of the population 15 years of age and older. Similarly, NPHS target population
includes household residents in all provinces and territories, and excludes persons living
on Indian reserves, on Canadian Forces Bases, and in some remote areas. Please see
NLSCY microdata file (Statistics Canada, 2009) for more detail on the LFS and NPHS
sampling design.
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The NLSCY consists of eight biennial cycles in total (data collection for cycles 1
to 8 occurred in 1994-95, 1996-97, 1998-99, 2000-01, 2002-03, 2004-05, 2006-07, and
2008-09, respectively). Households that reported having at least one child between the
ages of 0 and 11 years were selected as the household sample for cycle 1. For the first
cycle, the children comprising the sample were selected at random, up to a maximum of
four children per household. Approximately 25,000 children, ranging in age from
newborn to 11 years inclusive, were initially selected in the ten provinces. The analyses
for this study are based on data collected from the original cohort aged 10-11 years at the
first cycle; thus, the following discussion will be limited to the procedures and
characteristics that pertain to this cohort from the NLSCY longitudinal sample.
Across collection cycles, several changes were implemented in the sampling
strategy. At the second cycle, a maximum of two, instead of four, children were chosen
for whom data were to be collected. Beginning in the third cycle, children who were not
sampled included: deceased children, duplicate cases, children who were the wrong age
for the survey, households that were not traceable in the second cycle, households that
had moved permanently out of the country, children on Indian reserves, and households
that were adamant refusals. Beginning in the fourth cycle, it was decided to exclude
households after two consecutive cycles of non-response. Once respondents reach 18
years of age, it is the decision of the respondent, not the person most knowledgeable
(PMK), to respond to the survey. In other words, the response burden for the 18-year-old
is not as great as it may be for younger children. Thus, in order to retain more cases, at
the beginning of the fifth cycle, children who were 18-19 years of age were only
excluded if there were three consecutive cycles of non-response. Beginning in cycle 7,
the PMKs history of non-response was ignored for returning children who were 18 or
older.
At the first cycle, a household roster was completed for each household in the
NLSCY asking about basic demographic information and dwelling conditions. Once this
was completed, one child between the age of 0 and 11 was randomly selected from each
household, and a question was asked about whom in the household was the person most
knowledgeable (PMK) about the child. The PMK provided information about
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him/herself, his/her spouse/partner, the selected child, and household members. Data
from the PMK was collected in a face-to-face or telephone interview using computerassisted telephone interviewing (CATI). After the PMK gave permission, the interviewer
provided a separate questionnaire to each child aged 10 to 11 years. These children were
encouraged to self-complete the questionnaire in a private setting. Once completed, the
questionnaire was sealed in an envelope and the parent was not permitted to see the
completed questionnaire. In addition to the household component, questionnaires were
mailed to, and returned by, teachers and principals of school-aged children for whom
parental consent had been given.
At subsequent cycles, similar procedures were followed as mentioned above.
Namely, households that participated in the first cycle of the survey were contacted, both
the PMK and spouse were asked questions, children older than 10 years were provided
with self-complete questionnaires, and school-component questionnaires were mailed out
to participating children’s teachers and principals, when applicable.

3.1.3

Sample selection
The purpose of this study was to examine the association between body mass and

depressive symptoms as adolescents transition into young adulthood. Late adolescence
was chosen as a starting point as opposed to early adolescence or childhood because
depressive symptoms in these earlier developmental periods have a different pattern of
symptoms (Carlson & Kashani, 1988; Ryan, Puig-Antich, Ambrosini, et al., 1987;
Mitchell, McCauley, Burke, & Moss, 1988) and correlates (Jaffee, Moffitt, Caspi, et al.,
2002) compared to depressive symptoms in late adolescence and young adulthood.
Younger adolescents with depressive symptoms are more likely to experience agitation
and anxiety (Mitchell et al., 1988; Ryan et al., 1987), and older adolescents and young
adults are more likely to experience psychomotor retardation (i.e., slower thought
processes and physical activity; Ryan et al., 1987), which may be more closely related to
weight gain. Thus, the population of interest is Canadian youth beginning in late
adolescence and followed into young adulthood. Late adolescence is defined as 16-18
years, and young adulthood refers to 18-30 years (Rindfuss, 1991). Thus, for the purposes
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of the present study, an ideal nationally-representative population would prospectively
follow adolescents from 16 years of age to 30 years of age.
An initial longitudinal cohort of children (N = 2,488) participated in the NSLCY
survey in 1994-95 when they were 10-11 years old, in 1996-97 when they were 12-13
years old, in 1998-99 when they were 14-15 years old, in 2000-01 when they were 16-17
years old, in 2002-03 when they were 18-19 years old, in 2004-05 when they were 20-21
years old, in 2006-07 when they were 22-23 years old, and in 2008-09 when they were
24-25 years old.
In order to match the selected sample to the population of interest as closely as
possible, youth were selected from the NLSCY once they were 16-17 years of age (i.e.,
starting at cycle 4, in 2000-01). The sample size for this group is 1,895 (47.9% female),
representing 76% of the original cohort of 10-11 year olds at cycle 1. These youth were
followed into young adulthood, until age 24-25. Although, it would have been ideal to
have youth followed until age 30, the NLSCY currently only has data available until ages
24-25. Although sampling procedures and data collection did not begin when these youth
were 16-17 years of age, cross-sectional weights were used in all analyses (explained in
detail below). Thus, the sample selected for the present study represents the Canadian
population of adolescents aged 16-17 years as of January 1, 2001.
Statistics Canada provides information on the overall participation rates of the
initial 10-11 year olds for only five out of the eight cycles (96.1% in cycle 1, 91.2% in
cycle 2, 87.5% in cycle 3, 75.1% in cycle 6, and 61.9% in cycle 8). However,
participation rates for the entire longitudinal cohort (i.e., 0-11 year olds at cycle 1), as
compared to the first cycle, are as follows: 86.5%, 91.5%, 89.2%, 84.5%, 81.3%, 82.4%,
80.5%, and 68%, for cycles 1-8, respectively.

3.2 Measurement instruments
3.2.1

Body mass
Body mass was assessed by BMI, which was calculated as weight in kilograms

divided by height in meters squared. Height and weight were self-reported by individuals
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at all five ages (i.e., when participants were 16-17, 18-19, 20-21, 22-23, and 24-25 years
of age).
BMI was kept as a continuous variable in all analyses for several reasons. First, as
BMI does not measure fat directly, there is currently no consensus regarding cut-offs for
defining obesity in adolescents (Sweeting, 2007). In contrast with adult populations,
much less is known about the levels of risk associated with specific BMI levels in
children and adolescents. Due to this uncertainty, statistical approaches have often been
used in which the distribution for a population is determined and percentile values are
arbitrarily chosen to distinguish those with the highest BMI from the rest of the
population (e.g., 95th percentile). This approach has resulted in different reference groups
that identify different BMI cutoffs for obesity and overweight status based on sex and
age. For example, the CDC (Kuczmarski et al., 2002), the International Obesity Task
Force (IOTF; Cole, Bellizzi, Flegal, & Dietz, 2000), and the WHO (WHO, 2006) have all
identified different reference datasets for children and adolescents.
Second, retaining the continuity in BMI levels allows researchers to examine
individual heterogeneity over time, as well as associations between depressive symptoms
and normal variations in relative weight, as distributed throughout the population (Hasler,
Pine, Gamma, et al., 2004). Taking a more inclusive approach to body mass by
examining weight as a continuous variable may be more appropriate for understanding
the adverse health consequences and risk factors associated with higher BMI levels
(Allison, Fontaine, Manson, Stevens, & VanItallie, 1999; Li, Rana, Manson, et al., 2006;
Ogden, Carroll, Curtin, et al., 2006; Rashid, Fuentes, Touchon, & Wehner, 2003). Thus,
given the lack of research identifying validated cutoffs for youth, as well as the benefits
of examining weight as a continuous variable, the present study has kept BMI as a
continuous predictor and outcome so that readers can interpret results with reference data
as they see fit and results may be more meaningful within a population health context.

3.2.2

Depressive symptoms
Depressive symptoms were measured using the Centre for Epidemiological

Studies- Depression Scale (CES-D; Radloff, 1977). This scale is used to measure the

41

frequency of symptoms in the public at large. Questions focus on affective components
such as depressed mood, feelings of guilt and worthlessness, feelings of helplessness and
hopelessness, psychomotor retardation, and sleep disorders (Radloff, 1977). Within the
NLSCY, the original 20-item scale was reduced to 12 questions by Dr. M. Boyle of the
Chedoke-McMaster Hospital, McMaster University. This short version CES-D scale was
developed to assess levels of depressive symptoms during the past week, and has a
Cronbach’s alpha of .85 (Poulin, Hand, & Boudreau, 2005). Participants were asked to
rate on a four-point scale, from 0 (less than 1 day) to 3 (5-7 days), the occurrence of 12
feelings, such as “I felt depressed” or “I felt hopeful about the future”, during the
previous week. Three items on the scale were reversed scored so that higher scores
indicated greater depressive symptoms. Severity ratings for each symptom were summed
to form a continuous depressive symptom composite at each age, ranging from 0 to 36.
The internal consistency of the scale was similar across the five ages (α = .84, .83, .80,
.80, .82, for ages 16-17 to 24-25, respectively).
Depressive symptoms were kept as a continuous variable in all analyses because
depressive symptoms, like weight, occur on a continuum, and similar to those individuals
who are overweight but not yet obese, individuals who do not meet clinically significant
levels of depressive symptoms may still be at risk for mental health consequences
(Napolitano & Foster, 2008). Thus, in order to capture these population-level variations
in depressive symptomology, the present study focused on continuous depressive
symptoms rather than clinically significant depressive symptoms.

3.2.3

Age and sex
Age and sex were both reported by the PMK at the very first cycle. Age at each

subsequent cycle was derived by the child’s date of birth (as reported by the PMK during
the first cycle of data collection) and the date of interview. For ease of interpretation,
going forward, NLSCY cycles will be referred to by assumed median ages, with age 17
representing cycle 4 (i.e., baseline), age 19 representing cycle 5, age 21 representing
cycle 6, age 23 representing cycle 7, and age 25 representing cycle 8.
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Response rates for variables of interest across all five ages are presented in Table
2. For BMI, response rates ranged from 64.6-78.4% for males and 66.7-80.0% for
females. For CES-D scores, response rates ranged from 64.6-70.2% for males and 67.575.3% for females.

Table 2: Sample size across ages.
Variable
Males BMI
(n = 988) CES-D
Age

Age 17 (%)
681 (68.9)
653 (66.1)
988 (100.0)

Age 19 (%)
775 (78.4)
671 (67.9)
782 (79.1)

Age 21 (%)
647 (65.5)
643 (65.1)
650 (65.8)

Age 23 (%)
698 (70.6)
694 (70.2)
700 (70.8)

Age 25 (%)
638 (64.6)
638 (64.6)
641 (64.9)

Females BMI
(n = 907) CES-D
Age

681 (75.1) 696 (76.7) 676 (74.5) 662 (80.0) 605 (66.7)
678 (74.8) 665 (73.3) 683 (75.3) 677 (74.6) 612 (67.5)
907 (100.0) 713 (78.6) 695 (76.6) 677 (74.6) 613 (67.6)

Note. BMI: Body mass index. CES-D: Centre for Epidemiological Studies- Depression
Scale. Percentages reflect response rates for original cohort of 17 year olds selected from
cycle 4.

3.3 Analysis
3.3.1

Modeling strategy
As previously mentioned, the purpose of the present study is to assess the relation

between two developmental processes, body mass and depressive symptoms, as
adolescents transition into young adulthood. Latent growth modeling (LGM) was the
analytical technique used to assess this research question. The following section will
provide a justification of LGM as this analytical technique best represents the model of
development and best complements the conceptual and methodological components of
the present thesis.
In LGM, a single underlying growth trajectory for a construct is estimated for
each person across all ages (Curren & Bollen, 2001). In LGM, two latent factors are
estimated: an intercept and a growth parameter. The intercept represents the starting point
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(e.g., BMI at baseline). The intercept factor presents information about the mean, or
average, starting levels for individual growth curves, as well as the variance in starting
levels between individual growth curves (Duncan et al., 2006). The growth parameter
represents the rate of change of an individual’s trajectory. This growth parameter may
represent a linear slope or a more complex non-linear growth. Like the intercept factor,
the growth factor consists of two components: the average, and the variance. That is, the
growth factor presents information about the mean, or average, rate of change, as well as
the variance in the rate of change across individuals. Taken together, the means for the
intercept and growth represent the average trajectory for all individuals, and the variances
for the intercept and growth represent the variability in trajectories across individuals.
More information on techniques for estimating latent factors can be found in Duncan et
al. (2006).
Most previous research has examined the association between body mass and
depressive symptoms using traditional panel models [e.g., autoregressive cross-lagged
(ACL) approaches] to explore the temporal directionality of relations between depressive
symptoms and body mass. Using ACL models, researchers have evaluated whether level
of depressive symptoms at one point in time predicts body mass at a later point in time
(and vice versa), while accounting for rank-order stability in variables over time (i.e.,
they examine the extent to which the rank-order standing of an individual within a group
is stable or unstable over time; Duncan et al., 2006). Duncan and colleagues (2006)
identified several criticisms of developmental models that incorporate these
autoregressive effects.
First, these types of statistical techniques do not provide information about
developmental trajectories and individual-level change over time. In order to uncover the
nature of development, it is necessary to assess individual-level change over time (Singer
& Willett, 2003). Both body mass and depressive symptoms are developmental
constructs. That is, they both change over time and across the lifecourse. For example,
depressive symptoms increase throughout the adolescent years, peak during late
adolescence, and decline into young adulthood (Ge et al., 2006). Similarly, body mass
dramatically increases across childhood and adolescence and then levels off into
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adulthood (Kuczmarski et al., 2002). Only by examining developmental trajectories using
individual-level analysis could these changes over time be uncovered. Knowing that
neither body mass nor depressive symptoms are linear processes during the transition
between adolescence and young adulthood (Needham et al., 2010), it would be largely
disadvantageous to use a design that is only appropriate when the growth process is
irrelevant or known to be linear (Duncan et al., 2006). LGM identifies the process of
change, and is used in analytical situations where describing the growth of a construct is
of pivotal interest (Duncan et al., 2006), which is of central importance to the objectives
of this thesis. As previously mentioned, the major objectives of the present thesis include
examining individual trajectories of body mass and depressive symptoms as adolescents
transition into young adulthood, examining if changes in body mass over time are
associated with changes in depressive symptoms over time, and examining whether initial
levels of body mass predict changes in depressive symptoms over time, and/or vice versa.
A second criticism to ACL approaches is that they fail to provide adequate
generalization for three or more time points. When more than two time points are
included in a model, the best an autoregressive technique can do is examine change
scores between any two points in time. This constraint is particularly important with
respect to the present study, because, as highlighted above, both body mass and
depressive symptoms are assumed to be nonlinear processes. In order to identify a
nonlinear process, a minimum of three data points are required. Thus, an analytical
process that is able to adequately capture changes across three or more data points, as
LGM is able to do, is required.
Lastly, as autoregressive models are only able to predict changes in the rank order
of observations over time, they may fail to identify significant changes at the individual
and group level if rank order stays the same between two time points. While the ACL
approach may determine whether body mass at age 17 predicts depressive symptoms at
age 19, it cannot provide any indication of whether body mass predicts individual-level
change over many years in depressive symptoms, or whether the trajectories of these two
health indicators are related. According to Duncan and colleagues, “an appropriate
developmental model is one that not only describes a single individual’s developmental
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trajectory, but also captures individual differences in these trajectories over time” (p. 3;
2006). Using a person-centered approach, such as LGM, does provide this information.
Using LGM, body mass level at one point in time can be used to predict change in
depressive symptom scores across an extended period of time, and vice versa.
Furthermore, it is possible in LGM to assess whether the trajectories of body mass and
depressive symptoms are related to one another. Overall, utilizing a LGM approach will
provide the best match for the developmentally-focused research objectives of the present
study.
Research using a LGM approach to examine the developmental associations
between body mass and depressive symptoms is limited. In fact, only two studies have
utilized this analytic approach for this research question (Needham et al., 2010; Stice &
Bearman, 2001). While these studies represent important extensions in research on body
mass and depressive symptoms by adopting LGM, they suffer from a number of
limitations. Most notably, Needham and colleagues (2010) did not focus on a specific
developmental period. Examining four cycles over 15 years is a particularly long time
period of investigation, making associations vulnerable to confounding effects of
developmental periods and life transitions. At the other extreme, Stice and Bearman
(2001) examined only three cycles of data over two years, with 10-month intervals
between data collection points. Measuring at short intervals may not allow enough time
between cycles to effectively examine changes during a particular developmental period
such as adolescence, which spans over six years. No study using LGM has looked
specifically at the adolescent period and its transition into young adulthood. This is an
important limitation, as the later years of adolescence and early young adulthood involve
significant changes in both body mass and depressive symptoms (Ge et al., 2006; Kemper
et al., 1999).
In the present study, LGM was used to estimate individual trajectories of body
mass and depressive symptoms, as well as examine the association between body mass
and depressive symptoms, across five ages. This modeling strategy complements the key
objectives identified in the plan of study. The first objective was to examine individual
trajectories of body mass and depressive symptoms as adolescent’s transition into young
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adulthood. By using data from five ages (i.e., from ages 17, 19, 21, 23, and 25), this first
objective will be met by using LGM to model separate individual, or univariate,
trajectories for body mass and depressive symptoms. In addition to linear changes over
time, nonlinear changes for both body mass and depressive symptoms will be examined.
This will allow us to investigate whether changes in either health outcome are stable over
time, or if they plateau over time within the developmental period.
The second objective was to examine if changes in body mass over time are
associated with changes in depressive symptoms over time, and the third objective was to
examine whether initial levels of body mass predict changes in depressive symptoms over
time, or vice versa. LGM allows us to enter both univariate trajectories into a single dualtrajectory model (i.e., a multivariate model), where intercept and growth parameters are
estimated for both body mass and depressive symptoms. Specifying this multivariate
model allows us to examine if the rate of change for body mass is associated with the rate
of change for depressive symptoms, thus assessing if changes in body mass are associated
with changes in depressive symptoms. This multivariate model also allows us to examine
if the intercept for body mass predicts the growth for depressive symptoms, thus
assessing if initial levels of body mass predict changes in depressive symptoms over time
(and vice versa with the intercept of depressive symptoms predicting the growth of body
mass).
These analytical processes will be explained in greater detail in the results section.
Overall however, it is clear that using an LGM analytical technique would be the best
approach to study development, and more specifically, to investigate the key objectives
of the present thesis.

3.3.2

Data screening
Since all BMI scores were derived from self-reported height and weight measures,

there were some errors in both height and weight that needed to be examined prior to data
analysis. Checks were used to flag improbable heights over time, as well as biologically
implausible weight and BMI values. The following steps were taken to clean the height
variable before computing BMI for each age. First, each individual’s height trajectories
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were calculated from all eight cycles of data collection (n = 2,488). An assumption was
made that height could not decrease over time. Thus, any individual whose height
decreased at any adjacent point across the eight cycles of data collection was flagged.
One thousand and sixty-eight of such individuals were flagged for one data point (416 for
two data points, 90 for three data points, and 9 for four data points). Next, each height
trajectory was individually examined in order to determine the point (or points) that most
likely deviate from the rest of the trajectory. Once this point was flagged, an equation
was used to replace it by applying an estimation using adjacent heights and age at time of
interview.
In addition, heights were imputed using the same equation if an individual
provided data about weight, but not height. This was done as an attempt to maximize
available weight data in order to compute BMI, and 27 such cases were identified. All
analyses were rerun without these imputations, and similar results were found.
Weight was checked by deleting any biologically implausible values based on an
individual’s age and sex (Beck, Schaefer, Nace, et al., 2012). Three such deletions were
made. BMI and depressive symptoms across all ages exhibited acceptable skewness and
kurtosis [i.e., skewness < 3 and kurtosis < 10 – Kline, 2005] for structural equation
modeling.

3.3.3

Additional statistical considerations/adjustments

3.3.3.1

Model fit

Factor loadings are random, as each individual has a slightly different factor
loading (explained below). Since maximum likelihood functions were used as a result of
random factor loadings, traditional model fit indices, such as Comparative Fit Index
(CFI), Tucker Lewis Index (TLI), and Root Mean Square Error of Approximation
(RMSEA) could not be used. Instead, Akaike Information Criterion (AIC), Bayesian
Information Criterion (BIC), and loglikelihood tests were used to compare models. More
information on these fit indices may be found in (Burnham & Anderson, 2004). A
loglikelihood chi square difference test was determined to be significant at the α = .01
level.
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3.3.3.2

Adjustment for variation in age at baseline

Ideally, the application of LGM is dependent largely on data collection whereby
individuals are observed at the same point in time (Muthén, 2002). However,
participants’ ages ranged from 14.9 to 18.2 years at baseline. To calculate these age
differences at time of interview for baseline estimates, participants’ age at baseline was
subtracted by the median age (assumed to be 17, for ease of interpretability). Since
participants’ ages at baseline in this study varied, these variations from the median age at
baseline were controlled for, making the cohort homogenous with respect to starting age.

3.3.3.3

Adjustment for departure from balance design

An ideal application of LGM is also dependent on having equal spacing of
assessments for all individuals (Muthén, 2002). However, for all cycles in the NLSCY,
data collection spanned over two years. Thus, random factor loadings were used in each
model in order to account for the variation between interview times among participants
and across ages. For each age, factor loadings represented a participant’s exact age at
time of interview (in years) subtracted by the assumed median age at baseline (i.e., 17).
Thus, at age 19, factor loadings would have an approximate mid-point of 2 (ranging
between 1 and 3), at age 21, factor loadings would have an approximate mid-point of 4
(ranging between 3 and 5); at age 23, factor loadings would have an approximate midpoint of 6 (ranging between 5 and 7); and at age 25, factor loadings would have an
approximate mid-point of 8 (ranging between 7 and 9). The advantage of using this
method is that we do not need to make an assumption that every participant was
measured at the exact same time. Instead we can statistically allow measurement periods
for each person across each cycle, to vary, as they did in reality.

3.3.3.4

Missing data

There are two major forms of missing data in the present analysis. First, not
everyone who was originally sampled as a part of the original cohort at the first cycle of
NLSCY data collection participated at the fourth cycle. Since analyses for the present
study began at this cycle, when participants turned 16-17, only participants who
responded at age 16-17 were included from the original cohort of participants. Thus, for
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the present cohort, cross-sectional weights were computed by dividing each person’s
baseline cross-sectional survey weighting by the cohorts’ average survey weighting.
Cross-sectional weights were used in all analyses so that estimates at baseline represent
the Canadian population of 16-17 year olds as of January 1, 2001. Given the complexity
in the NLSCY sampling design with regard to stratification, multiple stages of selection,
and unequal probabilities of selection of respondents, cross-sectional weights must be
used in order to avoid bias in survey estimates and analyses (Statistics Canada, 2009).
The second form of missing data was due to the longitudinal sequential design of
the NLSCY. For example, after baseline, some participants did not complete the survey
at all time periods. Missing data are assumed to be independent from values of the study
measures; thus, it is reasonable to assume that these data are missing at random (Little &
Rubin, 2002). Mplus offers superior handling of missing data (using Full Information
Maximum Likelihood algorithm; FIML), for missing data points and for missing cases
due to attrition. FIML uses all available data to generate maximum-likelihood estimates
consisting of a vector of means and a covariance matrix among all variables in the data
set (Wothke, 1996). FIML retains cases missing one or more cycles, and therefore avoids
the use of biased parameter estimates that can occur with pair-wise or list-wise deletion
(Arbuckle & Wothke, 1999; Schafer & Graham, 2002).

3.3.3.5

Power/sample size calculations

Very little is known about the exact estimates needed to generate strong power
calculations for LGM because these types of analytic models are still considered
relatively new techniques (Muthén, 2002). Furthermore, because of the complexity of the
present model, as well as the large number of parameter estimates that are expected, more
general guidelines identified by the literature for SEM will be used to argue a sufficiently
large enough sample size. In general, the literature suggests that having about 200
subjects per group provides sufficient statistical power needed for any LGM analysis
(Hoyle, 1995; Ullman, 1996). Since a separate growth model will be estimated for each
sex on both health outcomes, a total sample size of 400 (i.e., 200x2) is needed for
sufficient statistical power for one model. The sample size from the original cohort at
baseline is 1,895, which indicates a large enough sample of adolescents and young adults
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to conduct an in-depth analysis of body mass and depressive symptom trajectories,
separately for males and females.
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Chapter 4

4

Results

4.1 Descriptive results
This chapter begins with a discussion of the characteristics of the sample,
including the average BMI and CES-D score at each age, as well as correlations between
BMI and CES-D score at each age. These descriptive statistics will be presented
separately for males and females. Following this, the findings from each research
objective will be presented. As previously mentioned, the objectives of this study are to:
1) examine individual trajectories of body mass and depressive symptoms as adolescents
transition into young adulthood; 2) examine if changes in body mass over time are
associated with changes in depressive symptoms over time; 3) examine whether initial
levels of body mass predict changes in depressive symptoms over time, and/or vice versa;
and 4) examine whether any of the above associations differ across sex.
The total sample size for this study was 1,895 (47.9% female). Table 3 outlines
the means and standard deviations for BMI and CES-D score across the five ages. As
expected, for both males and females, average BMI increased from adolescence to young
adulthood. For males, average BMI at age 17 was 23.0 and steadily increased by about
0.6 points at each age until age 23, where average BMI plateaus at around 24.9. When
males were 25 years old, the average BMI increased by about only 0.2 points. Standard
deviations in BMI for males tended to stay relatively consistent over time (i.e., at around
3.9 points). In females, compared to males, there was a more steady increase in average
BMI over time. At age 17, the average BMI for females was 22.4. This average steadily
increased to 22.8 at 19 years, 23.6 at 21 years, 23.9 at 23 years, and 24.5 at 25 years.
Average BMI for females was consistently lower than males at every age. Furthermore,
there were greater variances in average BMI for females than males at every age.
Standard deviations in BMI for females tended to increase over ages, from 4.2 to 5.4.
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Table 3: Means and standard deviations of study measures across five ages.
Age 16
M (SD)

Age 19
M (SD)

Age 21
M (SD)

Age 23
M (SD)

Age 25
M (SD)

BMI
Males
Females

22.97 (3.92)
22.43 (4.22)

23.64 (3.96)
22.77 (4.90)

24.33 (3.92)
23.57 (4.60)

24.89 (3.91)
23.86 (5.42)

25.05 (4.05)
24.55 (5.41)

CES-D
Males
Females

8.02 (5.72)
10.29 (6.41)

7.39 (5.58)
8.49 (6.11)

4.40 (4.59)
5.91 (5.96)

3.71 (4.04)
5.13 (4.93)

4.10 (4.37)
4.91 (5.38)

Age

16.9y (7m)

18.7y (7m)

20.8y (7m)

22.8y (7m)

24.8y (7m)

Variable

Note. BMI: Body mass index. CES-D: Centre for Epidemiological Studies- Depression
Scale. Higher scores for variables indicate higher BMI and CES-D scores. Scores
reflect adjusted means.

For both males and females, average CES-D score decreased from adolescence to
young adulthood. For males, average in CES-D score (out of a possible 36 points) was
8.0 at age 17. The average slightly decreased at age 19 to 7.4, and then drastically
decreased at age 21 to 4.4. Following these ages, the average CES-D score plateaus at 3.7
and 4.1 at ages 23 and 25, respectively. Standard deviations in CES-D score for males
tended to decrease over ages, from 5.7 to 4.1. For females, the average in CES-D score
was higher than the average in CES-D score for males at every age. In addition, the
average in CES-D score demonstrated a more gradual decline across ages for females
than they did for males. At age 17, the average in CES-D score for females was 10.3.
This average decreased to 8.5 at age 19, 5.9 at age 21, 5.1 at age 23, and 4.9 at age 25.
Although standard deviations in CES-D score for females also tended to decrease across
ages, these standard deviations were greater for females than they were for males, at all
ages.
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Table 4 outlines the correlations between BMI and CES-D score at each age,
separately for males and females. BMI was highly and significantly correlated across
ages, for both males and females. Adjacent age correlations for BMI were highest, with
Pearson correlation coefficients ranging from .76 to .84 for males, and from .74 to .84 for
females (all p’s < .001). However, BMI at age 17 was still highly correlated with BMI at
age 25 (.62 for males, and .67 for females; all p’s < .001).
CES-D scores were also highly correlated and statistically significant across ages
for both males and females, although to a lesser degree than BMI. As was the case with
BMI, adjacent age correlations for CES-D scores was highest, with Pearson correlation
coefficients ranging from .46 to .58 for males, and from .40 to .46 for females (all p’s <
.001). CES-D scores were also highly correlated between age 17 and age 25, with
Pearson correlation coefficients of .43 for males and .38 for females (all p’s < .001).
Adjacent age correlations for CES-D scores were consistently higher for males than
females, with the greatest difference between sexes occurring between ages 17 and 19,
where CES-D scores were correlated at .58 for males and .40 for females.
The correlation between BMI and CES-D score across ages was drastically
different for males and females. For males, BMI and CES-D score correlations at the first
two ages were not statistically significant (Pearson correlation coefficient of .02 at age 17
and .04 at age 19; all p’s > .05). However, during the next three ages, correlations were
negative and statistically significant. These correlations also increased in magnitude
across ages: -.08 at age 21, -.11 at age 23, and -.14 at age 25 (all p’s < .01). The largest
correlations for males were between BMI at age 21 and CES-D score at age 23 (-.21, p <
.001), between BMI at age 21 and CES-D score at age 25 (-.21, p < .001), and between
BMI at age 25 and CES-D score at age 23 (-.18, p < .001).
For females, a completely different pattern of correlations emerged. BMI and
CES-D score correlations within all ages were positive and statistically significant. The
correlation magnitudes increased until age 21, with Pearson correlation coefficients of .08
at age 17 (p < .05), .17 at age 19 (p < .001), and .22 at age 21 (p < .001). Following this
peak, correlation magnitudes decrease slightly, with correlation coefficients of .08 at age
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23 (p < .05), and .14 at age 25 (p < .01). The largest correlations for females were
between BMI at age 17 and CES-D score at age 19 (.30, p < .001), between BMI at age
19 and CES-D score at age 21 (.29, p < .001), and between BMI at age 17 and CES-D
score at age 21 (.25, p < .001).
The most striking sex differences between BMI score and CES-D score
correlations were evident for the last three ages, where for males correlations were
consistently negative and statistically significant, and for females, correlations were
consistently positive and statistically significant. For example, the correlation between
BMI score at age 21 and CES-D score at age 23 was -.21 for males and .13 for females
(all p’s < .01).
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Table 4: Correlations between BMI and CES-D score across five ages (males/females).
Variable

BMI 17 years
BMI 19 years
BMI 21 years
BMI 23 years
BMI 25 years
CES-D 17 years
CES-D 19 years
CES-D 21 years
CES-D 23 years
CES-D 25 years

BMI 19 years

BMI 21 years

BMI 23 years

BMI 25 years

CES-D 17 years

CES-D 19 years

CES-D 21 years

CES-D 23 years

.76*** / .84***
-

.67*** / .79***
.80*** / .76***
-

.68*** / .74***
.73*** / .74***
.84*** / .81***
-

.62*** / .67***
.74*** / .61***
.76*** / .70***
.81*** / .74***
-

.02 / .08*
-.04 / .14**
-.11* / .14**
-.06 / .10*
-.14**/ .07
-

.18*** / .30***
.04 / .17***
-.08 / .23***
-.02 / .24***
-.04 / .09*
.58*** / .40***
-

-.03 / .25***
-.03 / .29***
-.08** / .22***
-.10* / .24***
-.12** / .14**
.45*** / .33***
.46*** / .42***
-

.02 / .04
-.10* / .14**
-.21*** / .13**
-.11** / .08*
-.18*** / .14**
.48*** / .36***
.44*** / .26***
.57*** / .46***
-

CES-D 25 years

-.04 / .13**
-.08* / .13**
-.21*** / .18***
-.15*** / .03
-.14** / .14**
.43*** / .38***
.35*** / .22***
.42*** / .30***
.57*** / .41***
-

Note. BMI: Body mass index. CES-D: Centre for Epidemiological Studies- Depression Scale. Higher scores for variables indicate higher depressive symptoms and frequency of health risk behaviors.
† p < .06. * p < .05. ** p < .01. ***
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4.2 Growth trajectories
4.2.1

Objective 1: Univariate growth trajectories
The first objective of this study was to examine individual trajectories of body

mass and depressive symptoms as adolescents transition into young adulthood. This was
done by using data from five ages (i.e., age 17, 19, 21, 23, and 25) to model separate
univariate trajectories for BMI and CES-D scores.
The intercept and growth factors are each defined by setting factor loadings to
specify time points in the model. Since the intercept is constant over time, it is modeled
by constraining the loadings for each time point to equal 1. For each of the univariate
trajectories in the present thesis, the intercept factor loading was set to 1 at all time
points. This was done in order to estimate the starting point for each trajectory as the
baseline (i.e., age 17).
The growth factor in a LGM represents change, and thus is modeled by a
successive increase in factor loadings over time. For example, a linear increase in BMI
over five time points may be modeled by constraining the loadings of the five time points
to 0, 1, 2, 3, and 4, respectively. Growth factor loadings in the present thesis were set to 0
at baseline (i.e., age 17), and set to random factor loadings, with an approximate midpoint of 2 (at age 19), 4 (at age 21), 6 (at age 23), and 8 (at age 25). The exact growth
factor loadings reflect the variation in interview times among participants across ages.
They average at approximately 2, 4, 6, and 8 in order to reflect the approximate number
of years each interview took place after the baseline interview at age 17. For example, a
growth factor loading of 2 at age 19 represents an individual who was interviewed
exactly two years after the first interview. As previously mentioned, the advantage of
using random factor loadings is that they allow measurement periods for each person,
across each age point, to vary, as they did in reality.
Age at baseline (centered at 17) was entered as a covariate on the intercept for
both the BMI trajectory and the CES-D score trajectory. Age was centered at 17 (median
age) for baseline for ease of interpretability. As previously explained, age was entered as
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a covariate for the intercept of both univariate growth models in order to control for the
variations in age at baseline, thus making the cohort homogenous with respect to starting
age. Homogenizing the cohort was necessary as LGM applications assume that all
individuals are observed at the same point in time (Muthén & Muthén, 2004).
Separate univariate trajectories were identified for BMI and CES-D scores by first
testing each health outcome on a linear growth model followed by a quadratic growth
model. Quadratic associations were examined to determine if BMI and CES-D scores
followed a nonlinear growth trajectory from adolescence into young adulthood.
Nonlinearity was examined because, as previously mentioned, body mass increases
rapidly over childhood and adolescence and then plateaus during young adulthood
(Kuczmarski et al., 2002). Furthermore, depressive symptoms peak during late
adolescence and then decrease and plateau across young adulthood (Ge et al., 2006).
Thus, in order to examine these nonlinear growths, quadratic associations were
investigated. Chi square difference tests, using log likelihoods, were conducted to
compare the linear model to the quadratic model for each health outcome. The linear
growth model was chosen for all behaviours unless the χ2difference test between the
linear model and the quadratic model indicated a significant difference for the model at p
< .01. The model with the lowest AIC and BIC values was determined to be the better
fitting model of the two. The model with the linear growth factor was the more
parsimonious choice for BMI, χ2diff (6) = 8.96, p > .05. In contrast, the model with the
quadratic growth indicated a better fit than the linear model for CES-D scores, χ2diff (6) =
54.14, p < .001.
Once univariate models were identified, sex differences were assessed (objective
4). To do this, a chi square difference test was used to compare two sets of models: an
unconstrained model and a constrained model. The unconstrained model is the original
multi-group model in which parameters were estimated separately for each sex. This
model produced different parameter estimates (i.e., mean and variance for both the
intercept and growth) for males and females. The constrained model constrains the
variance for both the intercept and growth to be equal between males and females, thus
allowing the model to calculate the same estimates for both males and females without
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differentiating on sex. This constrained model is equivalent to examining trajectories of
BMI and CES-D scores for everyone in the sample. The chi square difference test
indicates if estimates conducted by separating sex are statistically significantly different
from estimates conducted without separating by sex. A significant chi square difference
test here would indicate that estimates from each model are different enough from one
another to statistically validate presenting results separately by sex (i.e., using the multigroup model identifying sex differences). The chi-square difference test indicated that
there were significant differences between the unconstrained model and the constrained
model for CES-D scores, χ2diff (3) = 28.89, p < .001. However, the chi-square difference
test indicated that there were not any significant differences between the unconstrained
model and the constrained model for BMI, χ2diff (2) = 5.67, p = .059.
Overall, chi square difference tests were used to determine the most parsimonious
model for identifying the trajectory of BMI and CES-D scores, and to determine whether
any sex differences exist in these trajectories. For BMI, the model with linear growth was
most parsimonious, and there were no statistically significant sex differences for the
trajectory of BMI. For CES-D scores, the model with a quadratic growth had a
significantly better fit than the model with a linear growth alone, and there were
significant sex differences for the trajectory of CES-D scores. Although, chi square
difference tests indicated no sex differences, BMI trajectories will still be separated by
sex for ease of interpretability and consistency across all research objectives.
Results of univariate trajectories are shown in Table 5. In addition, fitted
estimates for the univariate trajectories are presented in Figure 2. According to the
univariate models, average BMI at onset (i.e., age 17) starts at 23.3 for males and 22.5 for
females, and increases linearly across the study period, for both boys and girls, although
boys have slightly elevated initial levels and growth over time than girls. There was a
statistically significant amount of variance in the intercept and growth of BMI, for both
males and females, indicating a large amount of inter-individual differences in starting
points and growth of BMI for males and females. Although both variances were
significant, there were larger variances in BMI for females than males, in both the
intercept and growth.
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According to the univariate trajectories, males have an average CES-D score of
8.6 at onset (i.e., age 17), whereas females have an average CES-D score of 10.4 at age
17. While average BMI increased over time, average CES-D scores started out high at
age 17 and decreased over time. The quadratic trend indicates that, for this developmental
period, this decrease slows down and plateaus at about age 23. CES-D scores started out
higher, decreased at a slower rate, and plateau later for females compared to males.
Variances in the intercept of average CES-D scores were statistically significant for both
males and females, although these variances were larger for females compared to males.
For both sexes, variances were statistically nonsignificant for CES-D linear and quadratic
growth, indicating that there were few individual-level differences in the decline and
plateau of CES-D scores.
In summary, the first objective aimed to examine individual trajectories of body
mass and depressive symptoms as adolescents transition into young adulthood, by
modeling separate univariate trajectories for BMI and CES-D scores across five data
points from age 17 to 25. Average BMI growth followed a positive linear trajectory for
both males and females, with males having slightly (but not statistically significant)
higher initial levels and growth in BMI, compared to females. Average CES-D scores
decreased over time for both males and females. The trajectory for average CES-D scores
over time was nonlinear, such that there was a gradual decrease from age 17 to age 21,
and then CES-D scores tended to plateau into young adulthood. The trajectory for CES-D
scores was significantly different for males and females, such that, on average, females
had both a higher starting level of CES-D scores, as well as a slower decline in CES-D
scores, compared to males. The variances for both trajectories, with respect to intercept,
were statistically significant, meaning that there was a great deal of individual-level
variation from average in the starting point of BMI and CES-D scores. Variances for the
linear growth of BMI were also statistically significant for both males and females,
indicating a great deal of individual-level variation in the linear rate of change of BMI.
These variances were consistently larger for females than males. However, nonsignificant
variances for both growth elements of CES-D trajectories indicate small variation in the
rate of change of CES-D scores, for both males and females.
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Table 5: Parameter estimates of the multi-group univariate growth models of BMI and CES-D scores, by sex.

Variable

Intercept, Mean
(Variance)

Linear growth, Mean
(Variance)

Quadratic growth,
Mean (Variance)

BMI

Males
Females

23.29*** (11.50***)
22.47*** (15.25***)

0.27*** (0.06**)
0.25*** (0.12***)

-

CES-D

Males
Females

8.63*** (10.00***)
10.42*** (11.91***)

-1.54*** (0.45)
-1.36*** (1.35)

0.12*** (0.01)
0.08** (0.03)

Note . BMI = body mass index. CES-D: Centre for Epidemiological Studies- Depression Scale. The
total sample was N = 1793. All models had covariances between intercept and growth parameters
(and linear and quadratic parameters, when applicable), as well as a path from age at baseline to
intercept of health outcome.
** p < .01. *** p < .001.
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Body BMI
Mass Index
26
25.5
25
24.5
24
23.5

Males

23

Females

22.5
22
21.5
21
20.5
17

19

21

23

25

Midpoint age (years)

Depressive
Symptoms
CES-D
12
10
8
Males

6

Females

4
2
0
17

19

21

23

25

Midpoint age (years)

Figure 1: Fitted estimates for univariate trajectories.
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4.2.2

Objectives 2 and 3: Multivariate growth trajectory
Objectives 2 and 3 will be presented together in the following section because

they were both estimated within the same LGM. The second objective was to examine if
changes in body mass over time were associated with changes in depressive symptoms
over time.
Achieving this involved several analytical steps. First, the two separate univariate
trajectories identified from the first objective (i.e., the linear multi-group BMI trajectory,
and the quadratic multi-group CES-D scores trajectory) were both entered into a single
dual-trajectory model (i.e., a multivariate model). This multivariate model estimated an
intercept and growth for BMI, as well an intercept and growth for CES-D scores. Second,
within this multivariate model, a path between the BMI and CES-D scores for each age
was added, as well as a path between the intercept of BMI and the intercept of CES-D
scores. These paths were added in order to control for contemporaneous associations
between BMI and CES-D scores at each age. This control would ensure that any
prospective associations are not simply due to the correlation of both health outcomes at
each age (Stice & Bearman, 2001).
In addition, for both BMI and CES-D scores, a path was also added between the
intercept to the growth parameter in order to control for baseline levels of each health
outcome. Given the high stability of both health outcomes, this control would ensure that
any changes seen in either BMI or CES-D scores over time were not due to their
respective initial levels (Bradley et al., 2008).
Finally, a path was specified between the growth of BMI and the growth of CESD scores. This path represents the covariance in the linear growth of both health
outcomes, and allowed us to examine the second research objective of whether changes
in BMI were associated with changes in CES-D scores, after controlling for
contemporaneous associations at each age and initial levels of each health outcome.
The third objective was to examine whether initial levels of body mass predict
changes in depressive symptoms over time, and/or vice versa. In order to do this, two
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paths were simultaneously added to the same multivariate model: one in which the
growth of CES-D scores was regressed onto the intercept of BMI, and one in which the
growth of BMI was regressed onto the intercept of CES-D scores. These paths allowed us
to examine whether the intercept of BMI predicted the growth, or rate of change, in CESD scores, and whether the intercept of CES-D scores predicted the growth, or rate of
change in BMI. More specifically, these two coefficients will estimate: 1) the degree to
which initial levels of BMI at age 17 predict changes in the average decrease in CES-D
scores over time; and 2) the degree to which initial level of CES-D scores at age 17
predict changes in the average increase of BMI over time.
Since age at baseline was significant in the BMI univariate trajectory, but not the
CES-D scores univariate trajectory, a path from age at baseline was only specified to the
intercept of BMI in the multivariate model. In addition, the variance for the quadratic
growth term for CES-D scores was constrained to zero in the multivariate model since it
was statistically nonsignificant in the univariate latent growth model.
Results from the multivariate latent growth model are presented in Figure 3,
separately for males and females. For males, with regards to objective 2, the linear
growth of BMI was not associated with the linear growth of CES-D scores (p > .05). For
objective 3, the path from BMI intercept to CES-D scores linear growth was not
significant, β = -.018, p = .217, indicating that average starting levels of BMI did not
predict changes in CES-D scores over time, for males. However, the path from CES-D
scores intercept to BMI linear growth was negative and significant, β = -.016, p = .031,
indicating that, on average, adolescent males who had higher initial depressive symptoms
reported a slower increase in body mass over time, than adolescent males who did not
have higher initial depressive symptoms.
For females, with regards to objective 2, the linear growth of BMI was not
associated with the linear growth of CES-D scores (p > .05). For objective 3, the path
from BMI intercept to CES-D scores linear growth was negative and significant at a trend
level, β = -.026, p = .052, indicating that, on average, adolescent girls who had higher
initial body mass reported a slower decrease in depressive symptoms over time, than
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adolescent girls who did not have higher initial body mass. However, the path from CESD scores intercept to BMI linear growth was not significant, β = -.009, p = .364,
indicating that, on average, starting levels of depressive symptoms did not predict linear
changes in body mass over time, for females.
Variances in intercept and growth parameters for the multivariate model followed
a similar pattern to variances for the univariate models. Namely, large and statistically
significant variances were present in the intercept and linear growth of BMI, for both
males and females, as well as the intercept of CES-D. In addition, all variances were
larger in females than males.

4.2.3

Objective 4: Sex differences
As previously mentioned, the final objective was to examine whether associations

between initial levels of body mass and changes in depressive symptoms, and vice versa,
over time, vary across sex. In order to test whether the multivariate associations were
invariant across sex, a multi-group analysis was performed in the same manner in which
they were described for the univariate trajectories. Namely, invariance was tested by
comparing the multivariate model in which all parameters were constrained to be equal
between males and females to an unconstrained multivariate model in which all
parameters were free to vary. The chi-square difference test indicated that there were
significant differences between the unconstrained multivariate model and the constrained
multivariate model, χ2diff (5) = 35.78, p < .001, indicating that some of the associations
for the dual trajectory model differ across sex. More specifically, the association between
average initial BMI and average changes in CES-D scores, as well as the association
between average initial CES-D scores and average changes in BMI, were both different
for males and females (objective 3). However, the association between the growth of
BMI and the growth of CES-D scores were not different between males and females
(objective 2). As mentioned above, chi-square difference tests for univariate models
indicated that there were significant differences between the unconstrained model and the
constrained model for CES-D scores, but not for BMI (objective 1).
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Note: BMI = body mass index. CES-D = Centre for Epidemiological Studies- Depression Scale. Multivariate latent growth model
of BMI and CES-D across five ages. All values are unstandardized coefficients (as standardized coefficients cannot be estimated
using random factor loadings). Not all residuals are shown. Quadratic variance was constrained to zero. Covariances between BMI
and CES-D within each age also are not shown (e.g., BMI at age 17 and CES-D at age 17). Double-arrows refer to covariances
among the factors. Although not shown, a path from age at baseline was added to the intercept of BMI.
† p < .06. * p < .05. ** p < .01.

Figure 2: Multivariate model testing bidirectional pathways between BMI and CES-D.
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Chapter 5

5

Discussion
This chapter begins with a summary of the results. The summary includes a brief

overview of the results, focusing on the main findings from the univariate and
multivariate analyses pertaining to the study objectives. Following this summary, the
results for each objective are discussed in context with previous research on adolescents
and young adults. This discussion will provide a rationale and conceptual understanding
of the associations examined in the present thesis, as well as the important public health
implications of this study. The strengths and limitations of the current study, as well as
the important conceptual, methodological, and analytical suggestions for future research
are discussed next. Finally, this chapter concludes with an overall summary of the present
thesis and the importance of research in this area.

5.1 Summary of main findings
The main goal of this study was to identify the growth trajectories of body mass
and depressive symptoms as adolescent’s transition into young adults, and to examine the
associations between these growth trajectories. This main goal is composed of four
specific objectives. These objectives were to: 1) examine individual trajectories of body
mass and depressive symptoms as adolescent’s transition into young adults; 2) examine if
changes in body mass over time were associated with changes in depressive symptoms
over time; 3) examine whether initial levels of body mass predicted changes in depressive
symptoms over time, and/or vice versa; and 4) examine whether any of the above
associations differed by sex.
With respect to the first objective of examining individual trajectories of body
mass and depressive symptoms, results indicated that the average BMI trajectory
increased linearly from age 17 to 25, for both males and females. Average BMI levels
started out higher and increased at a faster rate for males than females, although this
difference was not statistically significant. There was a statistically significant level of
variation in both the starting levels and linear growth of BMI, especially for females,

67

indicating that a great deal of individual-level variation exists in BMI trajectories.
Furthermore, although there were increases over time in average BMI for both males and
females, it is important to note that average BMI was within the normal weight range at
all ages for both males and females, with the exception that average BMI for males at 25
years of age was within the overweight range (Kuczmarski et al., 2002).
The model-estimated trajectory for CES-D scores was negative and quadratic.
That is, CES-D scores started out higher, and decreased until about age 21 where scores
plateaud for the next two ages. The trajectory for CES-D scores was significantly
different for males and females, such that females had both a higher starting level of
CES-D scores, and a slower decline in CES-D scores, compared to males. Average CESD scores were within the minimal depressive symptoms range for both males and
females, at all ages (Poulin et al., 2005). Statistically significant variance was only
present in the intercept of CES-D scores for both males and females, and was greater for
females, indicating a high degree of individual-level variation in starting levels of CES-D
scores, particularly for females. On the other hand, variances in linear or quadratic
growth for the CES-D trajectory were not statistically significant, indicating that the
average decline and plateau for CES-D scores are relatively consistent across individuals.
With respect to the second objective of examining if changes in BMI were
associated with changes in CES-D scores, results showed that the linear growth of BMI
was not associated with the linear growth of CES-D scores, for either males or females.
That is, the rate of change in BMI was not associated with the rate of change in CES-D
scores.
For the third objective examining whether initial levels of body mass predicted
changes in depressive symptoms over time, results showed that starting levels of BMI
predicted change in CES-D scores over time for females, but not males. On average,
adolescent girls who had higher initial BMI levels reported a slower decrease in CES-D
scores over time, than adolescent girls who did not have higher initial BMI levels. This
association was significant at a trend level. Furthermore, starting levels of CES-D scores
predicted change in BMI over time for males, but not females. On average, adolescent
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males who had higher initial CES-D scores reported a slower increase in BMI over time,
than adolescent males who did not have higher initial CES-D scores.
Finally, with respect to the fourth objective, examining whether any of the above
associations differ across sex, results from chi square difference tests indicated that there
were significant differences between males and females in the univariate model for CESD scores, and the multivariate model with BMI and CES-D scores. However, there were
no significant gender differences in the univariate model for BMI.

5.2 Rationale for results
5.2.1

Objective 1
The results from the first objective were expected. As mentioned in the

hypotheses above, we expected trajectories of body mass to increase over time, and
trajectories of depressive symptoms to decrease and plateau from adolescence to young
adulthood. We also expected that, at all ages, body mass would be higher for males than
females, and depressive symptoms would be higher for females than males.
According to the CDC growth charts, body mass increases from childhood to age
20 are expected, and these increases follow a normal physical growth pattern
(Kuczmarski et al., 2002). Body mass at these developmental periods is also expected to
be higher for males than females, and reflects the fact that males generally have greater
muscle mass than females (Tanner, 1989).
Research on depressive symptoms in adolescents and young adults indicates that
during early adolescence, depressive symptoms increase, until they peak in late
adolescence, at around 17 or 18 years of age (Ge et al., 2006). This peak in depressive
symptoms during late adolescence is expected, as adolescence is a period of heightened
emotions (Dahl, 2004). Following this peak, depressive symptoms tend to decrease into
young adulthood (Needham et al., 2010). Adolescents tend to develop better emotionregulation abilities as they age and develop into young adults (Kemper et al., 1999), thus
accounting for the lower depressive symptoms we see over time. Although depressive
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symptoms tend to generally decrease from adolescence into young adulthood, rates are
still higher in females compared to males (Locke & Newcomb, 2001).

5.2.2

Objective 2
There is a paucity of previous multivariate LGM research on body mass and

depressive symptoms, especially during adolescence and young adulthood. For these
reasons, the second, third, and fourth objectives were examined in an exploratory way.
With respect to the second objective, changes in body mass over time were not
related to changes in depressive symptoms over time. As there were no studies in the
previous literature that examined this particular research question, inferences cannot
conclusively be made from the results presented here. However, because body mass and
depressive symptoms tend to follow very different individual trajectories from late
adolescence to young adulthood (i.e., body mass increases linearly and depressive
symptoms decrease nonlinearly), it may not be surprising that changes in one health
outcome over time are unrelated to changes in the other health outcome over time.
Regardless, further research needs to be done in order to validate the findings with
respect to this second objective.

5.2.3

Objective 3

5.2.3.1

Body mass affecting depressive symptoms

Results from the third objective will be divided into two components: baseline
body mass predicting change in depressive symptoms, and baseline depressive symptoms
predicting change in body mass. For body mass affecting depressive symptoms in males,
we found that, on average, BMI at age 17 did not predict growth in CES-D scores over
time. This finding is similar to what was mentioned in the literature reviewed above; that,
both studies which focused on the transition between adolescence and young adulthood,
and investigated associations in both males and females, reported nonsignificant
associations between body mass and subsequent depressive symptoms for males
(Goodman & Whitaker, 2002; Merten et al., 2008).
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Body mass during adolescence is largely driven by muscle mass in males (Tanner,
1989). This increased muscle mass may be explained through greater physical activity,
including greater participation in organized sports and strength training. Furthermore,
popularity in adolescence is attributed to athletics for males (Chase & Dummer, 1992).
Thus, it would be highly unlikely that, for the general population of adolescent males,
higher body mass would be associated with an increase in subsequent depressive
symptoms (Anderson, Cohen, Naumova, Jacques, & Must, 2007).
For females however, the story is quite different. The present study found that, on
average, adolescent girls with higher BMI at age 17 had a slower decline in CES-D
scores compared to their peers. That is, although on average there was a reduction in
depressive symptoms over time, females with higher body mass at age 17 were, on
average, much slower at reducing their depressive symptoms than females without higher
body mass at age 17; indicating that at each age, these females had higher depressive
symptoms on average than their peers.
These results are fairly consistent with the pattern of findings reported in the
literature review section pertaining to studies examining body mass affecting depressive
symptoms. More specifically, for female adolescents transitioning to young adulthood,
body mass may lead to higher levels of depressive symptomology. Merten and colleagues
(2008), for example, examined the association between body mass at age 12-18 and
depressive symptoms five years later and found that, among females, obesity in
adolescence was associated with higher depressive symptoms in young adulthood.
Similarly, Boutelle and colleagues (2010) found that for adolescent girls, obesity
predicted depressive symptoms one year later.
Whereas popularity in adolescence is attributed to athletics for males, it is
attributed to appearance for females (Chase & Dummer, 1992). Because females tend to
place a great deal of subjective importance on their physical appearance (Wadden &
Stunkard, 1987), female adolescents with higher body mass may be especially at risk for
developing subsequent depressive symptoms through the internalization of biased
attitudes (Boutelle et al., 2010). This internalization of biased attitudes may be the most
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relevant causal pathway to explain the association between higher body mass and higher
subsequent levels of depressive symptoms for females across adolescence and young
adulthood.
Although the internalization of biased attitudes is one potential causal pathway
explaining the association between initial body mass and subsequent depressive
symptoms for females, there are many other possible causal pathways, as explained in the
literature review. Functional impairment in females with higher body mass may also lead
them to develop higher depressive symptoms compared to their peers (Bornstein et al.,
2006; Lago et al., 2007). Physical activity tends to decline for adolescent girls, and this
inactivity may prospectively lead to the development of higher depressive symptoms over
time (Brown et al., 2005; Camacho et al., 1991; Farmer et al., 1988; Lampinen et al.,
2000; Paffenbarger et al., 1994; Strawbridge et al., 2002).
While weight-teasing and neurobiological causal pathways to depressive
symptoms may also play a role, they may not be as prominent in the present study
because of the age-group studied, as well as the conceptualization of body mass and
depressive symptoms. Weight-teasing tends to occur in childhood and young adolescence
and rarely as much as older adolescents age into young adults (Hill, 2005).
Furthermore, neurobiological causal pathways may play a role in the association
between obesity classification and subsequent clinically significant depressive symptoms,
but not in the association between high BMI and subsequent depressive symptoms. For
example, obesity, but not necessarily high BMI, has been shown to predict subsequent
depression through inflammatory pathways (Emery et al., 2007; Shoelson et al., 2007),
HPA dysregulation (Pasquali et al., 2006; Walker, 2001), and increased risk of diabetes
mellitus (Ajilore et al., 2007).

5.2.3.2

Depressive symptoms affecting body mass

With regards to the opposite direction of association (i.e.. depressive symptoms
affecting body mass), results indicated that, on average, high initial CES-D scores did not
lead to higher BMI growth in males or females. Although we found that depressive
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symptoms did not predict higher body mass in either males or females, the reasons for
this may be different. For girls, the association between depressive symptoms and
subsequent body mass may only be significant when considering clinically significant
depressive symptoms, which were not considered in the present study. For example,
Anderson, Cohen, Naumova, and Must, 2006 reported that a MDD diagnosis in
childhood and adolescence predicted a steeper increase in weight for females.
In addition, dose-response studies have reported that the number of times an
adolescent meets clinical criteria for a major depression diagnosis during adolescence
predicts an increased risk of obesity in young adulthood (Richardson, Davis, Poulton, et
al., 2003). These recurrent, or persistent, episodes of depression are much more common
for females than males (Richardson et al., 2003), thus making it more likely for
depression, when diagnosed at a clinical level, to lead to increases in body mass for
females.
In the literature review above, studies that investigated associations between
depressive symptoms and subsequent body mass in both males and females reported
nonsignificant associations for males (Goodman & Whitaker, 2002; Tanofsky-Kraff et
al., 2006). Furthermore, in line with our findings, there is some evidence that males are
inclined to lose instead of gain weight when depressed (e.g., Carpenter, Hasin, Allison, &
Faith, 2000). Carpenter and colleagues (2000) found that underweight status in men was
associated with an increased risk of clinical depression and suicidal tendencies. In
addition, using a community-based study of sixth grade students, Rhew and colleagues
(2008) found that adolescent boys with clinically significant depressive symptoms at
baseline reported lower subsequent BMI one year later, compared to their non-depressed
peers. Finally, there has also been some cross-sectional research supporting an inverse
relationship between depressive symptoms and body mass among adult men (Crisp &
McGuiness, 1975; Crisp, Queenan, Sittampaln, & Harris, 1980; Kittel, Rustin, Dramaix,
et al., 1978). Similarly, the correlational analyses of the present study showed significant
and negative relations between body mass and depressive symptoms for adolescent and
young adult males.
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As previously mentioned, body mass during adolescence is largely driven by
muscle mass for boys (Tanner, 1989), partially explained by greater physical activity and
participation in organized sports. Popularity for adolescent boys is largely attributed to
athletics and organized sport participation (Chase & Dummer, 1992) because males tend
to prefer a large and muscular body as opposed to a thin one (Herva et al., 2006). Boys
with depressive symptoms may be less likely to increase their body mass through
participation in physical and muscle-building activities because these activities occur in
highly social contexts during adolescence. Depressive symptoms also may be associated
with a lack of athletic ability in boys, which may be indexed by a low body mass.
Furthermore, a moderational process may occur, such that depressed males start out with
lower body mass (Carpenter et al., 2000), and also tend to gain less weight over time
(Barefoot et al., 1998).
Finally, for both males and females, the heterogeneity of depressive symptoms
may make it difficult to prospectively affect increases in body mass. More specifically,
depressive symptoms include either increased or decreased appetite, and there may be a
sub-sample of depressed adolescents who report losing weight, or a failure to gain weight
over time as opposed to gaining weight (Kendler, Eaves, Walters, et al., 1996). This
inherent heterogeneity in the manifestation of depressive symptoms may confound
associations between depressive symptoms and subsequent body mass, for both males
and females.

5.3 Implications
The results of the present study have many academic and public health
implications. One major such implication is the importance of considering sex in the
associations between body mass and depressive symptoms in adolescents and young
adults. These associations differ greatly for males and females, and these differences need
to be taken into consideration in future research, as well as within a public health
perspective. Females tend to place a greater importance on appearance and thinness than
males, and they are also more like to experience negative feelings, such as depressive
symptoms, associated with their weight status (Wadden & Stunkard, 1987). Thus for
females, higher body mass could be indicative of future mental health problem. For males
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however, it is particularly important to pay attention to lower weight status and
depressive symptoms. Depressed males may be failing to attain the proper nutrients and
exercise they need in order to build muscle mass. Thus, depressive symptoms in boys
may lead to a failure to fully physically develop.
A population-based strategy targeting these two health outcomes would be most
effective if it focused on preventing depressive symptoms in adolescent boys, and
preventing overweight conditions in adolescent girls. For males, attenuating the risk
factors for depressive symptoms early in the lifespan is critically important. In addition,
males with higher depressive symptoms should be closely monitored with regards to diet
and physical exercise in order to ensure proper development into young adulthood.
Since higher BMI levels in adolescent girls had an effect on their rate of change in
CES-D scores as young adults, it is important for adolescent girls to take the necessary
steps to achieving healthy body mass during the teenage years. Weight-related changes
can be promoted by parental and societal influences. Parents of teenagers can help in
many ways. First, since they are the primary models in developing the food preferences
and habits for their household, they can begin by evaluating their own lifestyles in terms
of health-related quality (Benton, 2004; Merten et al., 2008). Also, by practicing
authoritative parenting (Baumrind, 1966), parents can promote positive self-regulation
(Patock-Peckham, Cheong, Balhorn, & Nagoshi, 2001). This positive self-regulation in
their teens allows them make healthier food and activity choices of their own, while still
having guidance and monitoring from their parents (Merten et al., 2008).
On a societal level, interventions need to be developed addressing the
discrimination of individuals with higher body mass in educational, professional, and
social settings (Merten et al., 2008). These interventions are particularly important for
women, as research has shown that recruiters and employers judge these individuals
capabilities based on weight-related biases (Ding & Bornhop, 2005; Tunceli & Williams,
2006). Finally, school administrators and directors need to be aware of the detrimental
effect that poor nutrition and exercise habits on an adolescent’s psychological well-being
over time (Merten et al., 2008).
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Care providers should be aware of the extent to which body mass and depressive
symptoms interact in some individuals. More specifically, they should be alert to the
possibility of depressive symptoms in their patients with obesity, and should screen for
these symptoms appropriately, as well as monitor their changes over time (Faith et al.,
2011). Health care providers should also be aware of and monitor weight changes in
patients that present with clinically significant depressive symptoms.

5.4 Strengths
The major strength of the present study was that it addressed the majority of
within-study limitations of past research. These include: lack of consistency in measuring
body mass and depressive symptoms over time, failure to assess longitudinal change in
outcomes, using only two waves of data, failure to examine reciprocal relationships, and
a lack of transitional research between adolescence and young adulthood. The present
study used the same measures to assess body mass and depressive symptoms across all
five ages. That is, at all ages, self-reported height and weight were used to calculate BMI,
and self-reported CES-D scores were used to measure depressive symptoms. We assessed
longitudinal change in both health outcomes by controlling for baseline levels of each
outcome during analytical modeling. In order to effectively assess growth over time in
both outcomes, we used five data-points over an eight-year period. The present study
examined, simultaneously, the reciprocal prospective associations between body mass
and depressive symptoms. Finally, in order to gain an understanding of how these
developmental processes are associated as adolescents age, we assessed the prospective
associations between these two health outcomes during the transition from adolescence to
young adulthood.
In addition, strong conceptual, methodological, and analytical justifications were
made throughout the methods section in order to contribute to a level of consistency that
will ease cross-study comparisons in the future. First, late adolescence was chosen as a
starting point because depressive symptoms in earlier developmental periods has a
different pattern of symptoms (Carlson & Kashani, 1988; Ryan et al., 1987; Mitchell et
al., 1988) and correlates (Jaffee et al., 2002) compared to depressive symptoms in late
adolescence and young adulthood. Although, in order to fully capture young adulthood,
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an ideal follow-up period would have been until age 30 (Rindfuss, 1991), the constraints
of the data source used only allowed examination up to age 25. The NLSCY was chosen
because it is the largest population-based longitudinal study of Canadian children that
follows their development and well-being from birth to early adulthood (Statistics
Canada, 2009).
Second, BMI was kept as a continuous variable in order to take a more inclusive
population-based approach to body mass. Similarly, CES-D scores were measured as a
continuous variable in order to capture heightened depressive symptoms in individuals
who do not meet criteria for clinically significant depressive symptoms.
Third, in order to more accurately capture the developmental objectives of the
study, the analytical procedure of LGM was used as opposed to an autoregressive
modeling approach. No study to date has used LGM to examine, specifically, the
adolescent period and its transition into young adulthood. This is an important limitation,
as the later years of adolescence and early young adulthood involve significant changes
in both body mass and depressive symptoms (Ge et al., 2006; Kemper et al., 1999).
Finally, many steps were taken during the data screening and analysis phase to
ensure validity in results. These steps included: using checks to flag and correct
improbable height and BMI over time; adjusting for variation in age at baseline; adjusting
for the variation in interview times among participants and across ages; applying sample
weights so that estimates represent the Canadian population of 16-17 year olds as of
January 1, 2001; and using FIML to handle missing data by using all available data to
generate maximum-likelihood estimates.

5.5 Limitations
Although the present thesis had major strengths over previous studies, there were
also a few limitations. These limitations include: using BMI as a proxy for adiposity; use
of self-reported height and weight to calculate BMI; the low response rate for both BMI
and CES-D; and follow-up period and length of intervals. These limitations will be
discussed in greater detail below.
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The first limitation concerns using BMI as a proxy for adiposity. This limitation is
particularly relevant for the adolescent period, as gains in both muscle and bone mass can
be substantial (Tanofsky-Kraff et al., 2006). Thus, changes in BMI may reflect these
increases in muscle and bone mass, and not necessarily changes in fat mass. Although,
density-based methods (e.g., underwater weighting) and scanning methods (e.g., DEXA)
are the gold standard for assessing overall body fat and fat distribution, factors other than
accuracy in body fat estimation need to be considered when deciding on an ideal measure
of body fat (Power, Lake, & Cole, 1997). Factors such as accessibility, simplicity, cost
and ease of use, and acceptability are all important considerations. Thus, using gold
standard measures such as DEXA would not be feasible in a large-scale population study
since the test must be performed in a major medical facility, and the equipment is very
expensive and must be operated by a skilled technician (Lobstein et al., 2004). In
addition, the procedure itself takes about 20 minutes and requires a very cooperative
subject (Lobstein et al., 2004). Overall, feasibility restrictions exist for all of the densitybased and scanning methods, making them unsuitable as measures of body fatness for the
present study.
BMI has been recommended as the measure of choice for epidemiologic and
population-based research because it is relatively easy to implement (Dietz & Robinson,
1998). BMI also correlates well with direct measures of total body fat, including DEXA,
as well as with health measures such as blood pressure, adverse lipoprotein profiles,
atherosclerotic lesions, serum insulin levels, and diabetes mellitus in adolescent samples
(Dietz & Robinson, 1998). Overall, research has documented that BMI is a valid measure
of adiposity, especially for population-based research (Garrow & Webster, 1985).
A second major limitation concerns the use of self-reported height and weight to
calculate BMI. Individuals tend to under-estimate their weight and over-estimate their
height (Elgar et al., 2005; Danubio et al., 2008; Morrissey, Whetstone, Cummings, &
Owen, 2006), potentially leading to an inaccurate estimate of BMI. This inaccurate
estimate would be especially problematic if self-reported height and weight are
differentially biased between depressed and non-depressed individuals (Rhew et al,
2008). In this specific situation, prospective associations between BMI and depressive
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symptoms may be biased. For example, individuals who suffer from depression may be
more prone to negative self-perceptions and greater self-criticality (Lewinsohn, Gotlib, &
Seeley, 1997). This lower self-appraisal, in turn, may translate to more realistic height
and weight self-reports than the height and weight reported by non-depressed individuals
(Alloy & Abramson, 1988). Although a valid concern, there are several considerations
that need to be made with respect to this particular limitation.
First, these inaccuracies in self-reported height and weight reflect the specific
developmental period under examination (Rhew et al, 2008). Biased estimates from selfreported weights tend to be the greatest under age 14 (Himes & Faricy, 2001). Rhew and
colleagues (2008) also concluded that the specific developmental period of early
adolescence might be a time where self-reports are particularly inaccurate. Strauss (1999)
found that in young adolescents aged 12-16, inaccuracies were more likely to occur for
the younger aged youth compared to the older youth. Another study showed that BMI
under-reporting is minimal in young adults between ages 20 and 40 (Schutz & Woringer,
2002). Anderson and colleagues (2006) further commented that self-reported height and
weight tend to be more accurate in adults and older adolescents. Several studies have, in
fact shown a high correlation between BMI calculated from self-reported height and
weight and BMI calculated from measured height and weight for older adolescents and
young adults (Attie & Brooks-Gunn, 1989; Galambos, Almedia, & Peterson, 1990;
Himes, Hannan, Wall, & Neumark-Sztainer, 2005).
Second, the discrepancies between self-reports and physical measurements tend to
mainly occur at the extremes of the BMI distributions (Kuskowska-Wolk, Bergstrom, &
Bostrom, 1992; Sorensen, Stunkard, Teasdale, & Higgins, 1983). Thus, a report bias of
individuals under-reporting BMI at higher BMI levels would affect results by making
estimates conservative (Ternouth, Collier, & Maughan, 2009).
Finally, several validation studies have stated that the bias of self-report BMI is
too small to affect conclusions about associations in large-scale epidemiological studies
(Stunkard & Albaum, 1981; Stevens, Keil, Waid, & Gazes, 1990). Validation studies also
suggest that the self-report bias is unlikely to affect conclusions about associations
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between body mass and psychological outcomes, such as depressive symptoms,
particularly in longitudinal studies (Stunkard & Albaum, 1981; Stevens et al., 1990).
Authors suggest that the self-reported BMI biases associated with depressive symptoms
are most likely to operate in cross-sectional analyses instead (Hasler, Pine, Kleinbaum, et
al., 2005).
These biases are likely not to impact longitudinal studies because the self-report
measure is from the same individual over time, thus reducing the amount of bias to only
one source of bias over all ages. That is, by consistently relying on self-reported height
and weight throughout all ages, we have only a single source of bias. Thus, increases in
BMI over time cannot be due to the tendency for individuals to under-estimate their
weight and over-estimate their height, because the same individuals are providing
estimates for their height and weight over time. As previously mentioned, Franko and
colleagues (2005), had inconsistent reporting sources for height and weight, where selfreports were used at the first wave and measured height and weight at the second wave.
Thus, the increase in BMI may reflect a true consistency in BMI that was not captured in
the first wave because self-reports of height and weight would have had the effect of
lowering their initial BMI (Elgar et al., 2005; Danubio et al., 2008).
The third major limitation was the low participant response rate throughout all
ages. As Table 2 indicates, after age 17, participation rates dropped in subsequent cycles.
From ages 19 to 25, participation rates were 79%, 71%, 73%, and 66%, respectively. The
biggest decrease in participation occurred between age 17 and 19, where there was a 20%
drop in participation. A decrease in retention is expected to occur within longitudinal
studies (Hansen, Tobler, & Graham, 1990). In a meta-analysis on attrition rates, Hansen
and colleagues (1990) suggested that studies with retention rates above 71.8% at 24
months, and above 67.5% at 36 months, would be judged to have acceptable and
interpretable rates of retention. As retention rates were 79% at the age 19 (i.e., two years
after baseline), this level of attrition occurring between age 17 and 19 of the current study
is acceptable. Furthermore, at all ages within the current study, retention rates were
higher than the acceptable rate that was defined by Hansen et al., (1990) for three years
after baseline. These findings indicate that, although retention rates decreased over the
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course of the present study, at eight years after baseline, retention rates were still within
the acceptable range defined at three years after baseline. Although these retention rates
were acceptable, there is a possibility that data is not missing at random if individuals
with higher body mass and/or depressive symptoms were more likely to drop out of the
study.
The final major limitation of the present study is that the starting age point
examined, as well as the length in time of follow-up, may have affected our findings.
That is, we began our analyses at age 16-17, and measured change up until age 24-25.
Depressive symptoms at age 16 may not affect changes in body mass up until age 25. For
example, Richardson et al., 2003 examined this research question using two cohorts; one
cohort was 11-15 years old at baseline and 26 at follow-up, and the other was 18-21 years
old at baseline and 36 at follow-up. The authors found that depression at ages 11-15 was
not a significant predictor of obesity at age 26 for either males or females. However,
females with depression at ages 18-21 had an increased risk of obesity at age 26. This
study suggests that the effect of depressive symptoms on subsequent body mass may be
more likely to occur when the time points are closer together rather than farther apart.
Thus, examining the associations over an 8-year period, beginning at 16-17 years, may
have been too long or too early to see an association between depressive symptoms and
subsequent body mass.
These limitations, although not major, should be examined in greater detail in
future studies researching the association between body mass and depressive symptoms.
Namely, associations should be examined using gold standards for BMI assessment,
including measured height and weight. In addition, analyses should be replicated on
various ages and interval lengths between adolescence and young adulthood in order to
best understand what is occurring during this developmental transition.

5.6 Future research
The public health implications presented above can only be drawn from tentative
conclusions from the exploratory results reported in the present study. Several authors
have concluded that better-designed studies are needed to draw more reliable conclusions
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on the prospective association between body mass and depressive symptoms (Fabricatore
& Wadden, 2004; Liem et al., 2008). For example, Friedman and Brownell, 1995,
suggested that authors include large, nationally representative samples, consistent
definitions and measurements of body mass, valid assessment tools, and appropriate
control groups. Faith et al., 2001 also encouraged authors to use standardized and
validated assessments of depressive symptoms, as well as control for baseline levels of
the follow-up dependent variable.
As previously mentioned, the variations that occur at the conceptual,
methodological, and analytical levels, may explain a great deal of the disparity in results
of studies investigating the prospective association between obesity and depression.
Conceptually, consistencies do not exist with regards to the developmental periods
studied, the operationalization of body mass and body mass comparison groups, the
operationalization of depressive symptoms, and the populations studied.
Methodologically, there are large variations among the length of intervals, source of
height and weight measurements, reference tools for establishing body mass cutoffs, and
tools for measuring depressive symptoms. Analytically, studies varied in the number of
measurement points used for analyses, the statistical techniques they used, and the
covariates controlled for to assess prospective associations between body mass and
depressive symptoms.
Thus, as it currently stands, public health implications can only be drawn from
tentative conclusions. A major goal for future studies should be to strive toward greater
consistency in this area of research. A higher level of precision in conceptualizations,
methodologies, and analyses used across studies would effectively translate into less
variety in reported results. Having less variety in results across studies would allow
researchers to confidently state research conclusions and public health implications based
on evidence. In order to build research towards this higher level of consistency between
studies, authors should strive to provide strong justifications for the operationalization of
concepts, as well as the methodologies and analytical techniques used.
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In addition to greater consistency between studies, future research needs to
examine more clearly the causal mechanisms involved in the prospective association
between body mass and depressive symptoms (Luppino, de Wit, Bouvy, et al., 2010).
Mediators should be selected based on the direction of the association examined and the
theoretical rationale. As mentioned in the literature review above, potential causal
pathways for body mass affecting depressive symptoms include the internalization of
biased attitudes towards obesity, weight-teasing, neurobiological causal pathways, and
functional impairment. The potential causal pathways through which depressive
symptoms affects body mass include neurobiological causal pathways and affect
regulation, and impaired sleep quality and physical inactivity. Once research has clearly
established whether prospective associations between body mass and depressive
symptoms exist, these causal pathways need to be explored in order to understand the
mechanisms linking their association.
Several studies have also reported null results when examining the prospective
association between body mass and depressive symptoms (Clark et al., 2007; Goodman
& Whitaker, 2002; Jansen et al., 2008; Rhew et al., 2008; Tanofsky-Kraff et al., 2006).
These studies are also important, and reasons for null results for a particular
developmental group should be more closely examined. For example, one line of
reasoning may be that perception of and dissatisfaction with weight may be of greater
importance for predicting depressive symptoms than weight per se (Stice, Hayward,
Cameron, Killen, & Taylor, 2000). For example, Jansen and colleagues (2008) reported
that body weight perception, and not weight status (self-reported or measured), was
associated with mental health indicators among 12-13 year-olds.
This association may be especially relevant for adolescent and young adult
females than males, given the higher level of concern for being thin. According to Kittel
and colleagues, adolescent girls aged 11-19 reported significantly less satisfaction with
their bodies than adolescent boys (1978). In addition, Douty and colleagues found that
59% of normal-weight female college students reported low satisfaction with their bodies
(Douty, Moore, & Hartford, 1974). In another study, approximately 50% of girls in grade
10-12 believed that they were overweight, and nearly two-thirds wanted to lose weight
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(Stunkard, 1957). Most of the boys however were either satisfied with their weight or
believed they were too thin. Interestingly, the prevalence of overweight status was
identical in both groups. These findings highlight the importance of perception in the
association between body mass and depressive symptoms, particularly for females.
Stice and Bearman (2001) investigated associations within a sample of female
adolescents from northern California, using three cycles of data over 10-month intervals.
The authors hypothesized that neither starting levels of BMI nor changes of BMI over
time would affect changes in depressive symptoms over time. Instead it was hypothesized
that other variables would explain the growth in depressive symptoms across
adolescence, including perceived pressure to be thin, thin-ideal internalization, body
dissatisfaction, dieting, and bulimic symptoms. Growth curve analysis was used to
examine whether initial levels of BMI predicted change in depressive symptoms over
time, and whether change in BMI predicted change in depressive symptoms over time.
Neither of these associations were significant. However, all other variables hypothesized
to explain changes in depressive symptoms were significant. The authors concluded that
body image and eating disturbances, but not BMI, contribute to the growth in depressive
symptoms among female adolescents. Overall, these mechanisms need to be explored
more clearly in future research.
Finally, it would also be useful for future studies to examine associations across
different developmental periods (Faith et al., 2011). We cannot currently infer causality
because increases in body mass and depressive symptoms may have begun before age 17.
Therefore, there may be a different temporal picture before these ages as well as after age
25. Future research is needed to apply the same methodologies to early adolescence as
well as adulthood in order to better understand the predictive relationship between body
mass and depressive symptoms. The association is most likely a bidirectional association,
but different directional associations may apply depending on age group and sex.
Although depressive symptoms in adolescence did not predict higher body mass in young
adulthood in the present study, an individual’s mental state may begin to influence weight
status as they become older. For example, when examining women 22-27 years old at
baseline, Ball and colleagues (2009) found that decreases in weight predicted increases in
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depressive symptoms three years later. For this age group, body image issues may not be
as prominent in females, and instead, decreases in weight could reflect the occurrence of
stressful life events, resulting in weight loss and depressive symptoms. Overall, exploring
the associations across the lifecourse is important in order to fully understand
developmental influences on both body mass and depressive symptoms.

5.7 Conclusion
In conclusion, the goal of this thesis was to examine longitudinally the
associations between body mass and depressive symptoms during the transition from
adolescence to young adulthood, and to investigate if and how these associations differ
for males and females. It was conducted in order to address the major limitations and
gaps of previous research in this area, as well as to contribute to some level of
consistency that will help make cross-study comparisons possible in the future. Results
showed that, on average, adolescent girls with higher initial BMI levels reported a slower
decrease in CES-D scores over time, than adolescent girls who did not have higher initial
BMI levels. In addition, on average, adolescent males with higher initial CES-D scores
reported a slower increase in BMI over time, than adolescent males who did not have
higher initial CES-D scores.
Understanding the development and course of body mass and depressive
symptoms requires a lifecourse perspective for many reasons. First, both of these health
outcomes have determinants early in life, and can often persist from adolescence into
adulthood (Bradley et al., 2008; Guo et al., 2002). They can develop into chronic
conditions that most likely require lifelong monitoring and management (Schwartz,
1998). Thus, studying how body mass and depressive symptoms independently change,
as well as how they are associated over time, will aid in understanding the course and
consequences of both health constructs. Furthermore, understanding the predictive factors
associated with changes in body mass, as well as the predictive factors associated with
depressive symptoms, is important for preventing negative health outcomes across the
lifecourse. Finally, preventing increases in either body mass or depressive symptoms will
be most effective when it is informed by an understanding of the etiological pathways
involved in their development (Anderson et al., 2006).
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Appendix
Appendix A: Supplementary Literature review tables.
Table 1. Studies examining body mass as a predictor of depressive symptoms.
Author(s),
Year

Sample
Characteristics

Body Mass
measure

Depressive
Symptoms
measure

Anderson,
Murray,
Johnson,
et al.,
2011

Random sample from
multi-center grouprandomized
intervention trial in
middle-school girls
from 6 states in the
United States.
Hispanic, nonHispanic black, and
non-Hispanic White
were only included.

Measured
H&W.
Categorical
(CDC
referenceobese vs. not
obese).
Continuous
(BMI zscore).

CES-D
(SR).
Categorica
l (scores ≥
24 =
clinically
significant
depressive
symptoms).
Continuous
(depressive
symptoms).

Sample size : 918
Baseline age (y) : 11
Follow-up : 2 cycles
over 2 years.
Sex : Females

Covariates

Age, Time typically
spent home alone after
school, Lunch type
(free/reduced), Race .
Baseline dependent
variable . Controlled in
analyses.Excluded in
analyses.
Moderation analyses :
Obesity X Race

Analysis type

Multivariate logistic
regression . Unadjusted
and adjusted ORs and
95% CIs were calculated
for obese status (obese vs.
Not obese) at C1 on
subsequent CSDS 2 years
later.
Multivariate linear
regression using
depressive symptoms
scores.
Moderation analyses : Sig
(Race)

Unadjusted odds ratio (95% Adjusted odds ratio (95%
confidence interval) or other confidence interval) or other
statistics reported
statistics reported
Not adjusted for baseline
dependent variable.
White: 2.48 (1.93, 3.19).
Black: 1.03 (0.46, 2.31).
Hispanic: 0.86 (0.38, 1.94).

Controlled baseline
dependent variable.
White: 2.09 (1.44, 3.02).
Black: 1.29 (0.57, 2.88).
Hispanic: 0.76 (0.31, 1.85).
Excluded baseline
dependent variable.
White: 2.5 (1.57, 3.98).
Black: 0.98 (0.16, 5.97).
Hispanic: 0.72 (0.26, 1.95).
Results using continuous
variables were consistent with
results using dichotomous
variables (results not shown).

Observed relationship

Obesity status predicted
subsequent clinically
significant depressive
symptoms (CSDS) only
for White females, both
before and after
covariate adjustement,
and both when baseline
CSDS were controlled
for or when females with
baseline CSDS were
excluded.
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Table 1. Studies examining body mass as a predictor of depressive symptoms (continued).
Author(s),
Year

Sample
Characteristics

Ball,
Community-based
Burton, & study of young women
Brown,
in Australia.
2009
Sample size : 6677
Baseline age (y) : 2227
Follow-up : 2 cycles
over 3 years.
Sex : Females

Boutelle,
Hannan,
Fulkerson,
et al.,
2010

Body Mass
measure

SR H&W.
CES-D-10
Categorical (SR).
(WHO
Categorica
classifications- l (scores ≥
underweight, 10 =
normal
clinically
weight,
significant
overweight, depressive
obese).
symptoms).

Measured
H&W.
Categorical
(CDC
referenceSample size : 496
not
Baseline age (y) :
overweight,
~13.5
overweight,
Follow-up : 4 annual obese).
cycles
Sex : Females
Community-based
study of adolescents in
metropolitan area of
Austin, Texas.

Depressive
Symptoms
measure

Covariates

Education, Marital
status, Occupation,
Smoking status, Parity
status, Serious health
problems/disability,
Physical activity .
Excluded pregnant
women.
Baseline dependent
variable. Controlled in
analyses.
Age, Early puberty
status.

K-SADS
(SR).
Continuous
(depressive Baseline dependent
symptoms). variable. Controlled in
analyses. Excluded in
analyses.

Analysis type

Multivariate logistic
regression . Crude and
adjusted ORs and 95%
CIs were calculated for
the influence of C1 weight
status (underweight,
overweight, obese, vs.
normal weight) on
subsequent CSDS.

Unadjusted odds ratio (95% Adjusted odds ratio (95%
confidence interval) or other confidence interval) or other
statistics reported
statistics reported
All ORs not adjusted for
baseline dependent
variable .
Underweight 1.26 (0.99,1.6):
Overweight 1.32 (1.14,
1.53); Obese 1.81 (1.50,
2.18).

Linear regression.
Not presented.
Adjusted coefficients with
GEE to calculate influence
of obesity status
(overweight, obese, vs.
not overweight) the
previous year on
depressive symptoms the
subsequent year.

Observed relationship

Underweight: 1.09 (0.83,
1.42); Overweight: 1.21
(1.03, 1.43); Obese: 1.33
(1.08, 1.65).

Overweight and obese
females, compared with
normal weight females,
had higher risk for
clinically significant
depressive symptoms at
follow-up, both before
and after covariate
adjustment. NS for
underweight females.

Controlled baseline
dependent variable.
Overweight: β = 0.0016 (SE
= .03, p = .96); Obese: β =
0.17 (SE = .05, p .01).

Overweight status was
not associated with
subsequent depressive
symptoms. Obese status
was associated with
subsequent higher
depressive symptoms
when compared to
females who were not
overweight.

Excluded baseline
dependent variable.
Did not mention results.
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Table 1. Studies examining body mass as a predictor of depressive symptoms (continued).
Author(s),
Year

Clark,
Haines,
Head, et
al., 2007

Sample
Characteristics

Body Mass
measure

Depressive
Symptoms
measure

Measured
SMFQ
H&W.
(SR).
Categorical Categorica
(United
l (scores ≥
Kingdom
8 = clinically
reference
Sample size : 1513
significant
Baseline age (y) : 11- curve
depressive
14
classifications- symptoms).
Follow-up : 2 cycles overweight:
over 2 years
BMI > 95th
Sex: Both
percentile,
obese: BMI
> 85th
percentile).
Community-based
sample of adolescents
attending school in
East London.

Covariates

Analysis type

Age, Gender, Eligibility
for free school meals,
Ethnicity, General
health status, Longstanding illness,
Smoking, Alcohol use,
Drug use, Physical
activity.

Multivariate logistic
regression . Crude and
adjusted ORs and 95%
CIs were calculated for
the influence of C1 weight
status (overweight, obese,
vs. not overweight) on
subsequent CSDS.

Baseline dependent
variable. Controlled in
analyses. Excluded in
analyses.

Moderation analyses :
NS (Gender)

Moderation analyses :
Gender X Age

Unadjusted odds ratio (95% Adjusted odds ratio (95%
confidence interval) or other confidence interval) or other
statistics reported
statistics reported
Not adjusted for baseline
dependent variable .
Overweight: 1.20 (0.95,
1.53); Obese: 1.04 (0.80,
1.36).

Controlled baseline
dependent variable.
Overweight: 1.16 (0.90,
1.50); Obese: 0.99 (0.75,
1.30).
Excluded baseline
dependent variable.
Similar results (not presented).

Observed relationship

Neither overweight
status nor obesity status
predicted subsequent
clinically significant
depressive symptoms,
either before or after
covariate adjustement.
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Table 1. Studies examining body mass as a predictor of depressive symptoms (continued).
Body Mass
measure

Depressive
Symptoms
measure

Covariates

Analysis type

SR H&W.
Categorical
(CDC
referencenot obese,
obese; for
participants
20 years and
older at
Sample size : 9374
follow-up,
Baseline age (y) : 12- obese: BMI
≥ 30).
19
Follow-up : 2 cycles
over 1 year
Sex : Both

Modified
CES-D-18
(SR).
Categorica
l (scores ≥
24 for
females and
≥ 22 for
males =
clinically
significant
depressive
symptoms).

Level 1 covariates: Age,
Gender, Race (White
non-Hispanic/ Black
non-Hispanic/
Hispanic), Parent
education, Two parents
in the home vs. Other.
Level 2 covariates: Selfesteem, Smoking,
Delinquent behavior,
Low physical activity.

Multivariate logistic
regression . Unadjusted
and adjusted ORs and
95% CIs were calculated
for obese status (obese vs.
Not obese) at C1 on
subsequent CSDS 1 year
later.

Author(s),
Year

Sample
Characteristics

Goodman
&
Whitaker,
2002

Nationally
representative cohort
of adolescents in the
US.
Non-Hispanic White,
non-Hispanic Black,
and Hispanic were
included only.

Baseline dependent
variable. Controlled in
analyses.
Moderation analyses :
Self-esteem X CSDS,
Smoking X CSDS,
Delinquent behavior X
CSDS, Low physical
activity X CSDS

Moderation analyses :
NS (All)

Unadjusted odds ratio (95% Adjusted odds ratio (95%
confidence interval) or other confidence interval) or other
statistics reported
statistics reported

Observed relationship

Level 1 covariates: 1.16
(0.81, 1.65).
Level 1 and 2 covariates: NS
(results not reported).

Those who were obese
at baseline did not have
increased risk of
clinically significant
depressive symptoms at
follow-up.

9.9% of those obese at C1
had CSDS at follow-up,
compared with 8.7 of those
not obese at baseline (p =
0.43).
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Table 1. Studies examining body mass as a predictor of depressive symptoms (continued).
Author(s),
Year

Sample
Characteristics

Body Mass
measure

Depressive
Symptoms
measure

Herva,
Laitinen,
Miettunen,
et al.,
2006

Community-based
study of adolescents in
two provinces of
Finland (all
Caucasian).

SR H&W.
Categorical
(internal
referencesoverweight:
85th-95th
Sample size: 8451 percentile,
Baseline age (y) : 14 obese: BMI
Follow-up : 2 cycles ≥ 95th
over 17 years
percentile)
Sex : Both

HSCL.
Categorica
l (three
different
score cutoffs used =
1.55, 1.75,
2.01).

Covariates

Analysis type

Father`s social class,
Family type, Chronic
somatic disease,
Smoking, Alcohol use.

Multivariate logistic
regression . Crude and
adjusted ORs and 95%
CIs were calculated for
the influence of C1 weight
Baseline dependent
status (overweight, obese,
variable. Did not control vs. not overweight) on
for or exclude in analyses. subsequent CSDS status.
Moderation analyses :
Stratified by gender.

Unadjusted odds ratio (95% Adjusted odds ratio (95%
confidence interval) or other confidence interval) or other
statistics reported
statistics reported

Observed relationship

Overweight status at age
14 did not predict
subsequent clinically
significant depressive
HSCL cut-off of 1.55.
HSCL cut-off of 1.55.
symptoms (CSDS) at
Males: obese 1.15 (0.79,
Males: obese 1.08 (0.72,
any cut-off point. When
1.69).
1.61).
Females: obese 1.34 (0.98, Females: obese 1.33 (0.97, using a HSCL cut-off of
1.75, obese females at
1.82).
1.83).
age 14 had higher risk
of CSDS at 31,
HSCL cut-off of 1.75.
HSCL cutoff of 1.75.
compared with not
Males: obese 1.26 (0.80,
Males: obese 1.18 (0.73,
overweight females.
1.96).
1.89).
Females: obese 1.63 (1.16, Females: obese 1.64 (1.16, When using a HSCL
cutoff of 2.01, males
2.29).
2.32).
with obesity at 14 had
higher risk of CSDS at
HSCL cut-off of 2.01.
HSCL cutoff of 2.01.
Males: obese 1.94 (1.07, Males: obese 1.97 (1.06, 31, compared with not
overweight males.
3.52).
3.68).
Females: obese 1.49 (0.89, Females: obese 1.55 (0.93,
2.47).
2.59).
All HSCL cut-offs for
overweight : NS.

All HSCL cut-offs for
overweight: NS.
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Table 1. Studies examining body mass as a predictor of depressive symptoms (continued).
Author(s),
Year

Merten,
Wickrama,
&
Williams,
2008

Rhew,
Richardso
n, Lymp,
et al.,
2008

Sample
Characteristics

Body Mass
measure

Depressive
Symptoms
measure

Covariates

Nationally
SR H&W.
representative cohort Categorical
of US adolescents.
(CDC
referenceSample size : 7881
not obese,
Baseline age (y) : 12- obese).
18
Follow-up : 2 cycles
over 6 years
Sex : Both

CES-D-9
(SR).
Continuous
(depressive
symptoms).

Parental education,
Family economic
hardship, Young adult
status attainment, Race.

Community-based
study of sixth grade
students from public
middle schools in
Seattle, Washington.
Oversampled students
scoring high on
depression or
disruptive behavior.
Sample size : 446
Baseline age (y) : ~12
Follow-up : 2 cycles
over 1 year
Sex: Both

SR H&W.
Measured
H&W
(n=165).
Categorical
(CDC
referencenot
overweight,
overweight,
obese).

Baseline dependent
variable. Controlled in
analyses.
Moderation analyses :
Gender X Obesity,
Obesity X Race
MFQ (SR). Gender, Household
Continuous income, Education of
(depressive primary caregiver,
symptoms- Physical development,
log
Race (Black, Pacific
transformed) Islander, Other).
.
Baseline dependent
variable. Controlled in
analyses.
Moderation analyses :
Depression X Gender

Analysis type

Unadjusted odds ratio (95% Adjusted odds ratio (95%
confidence interval) or other confidence interval) or other
statistics reported
statistics reported

Multivariate linear
N/A
regression . Adjusted
coefficients to estimate
influence of obesity status
(obese vs. not obese) in
adolescence on
subsequent depressive
symptoms in young
adulthood.

Females.
β = 0.03, SE = 0.19, p <
.001.
Males.
β = 0.01, SE = 0.14, NS.

Observed relationship

Among females, obesity
in adolescence was
associated with higher
depressive symptoms in
young adulthood. No
significant associations
between obesity and
depressive symptoms
for males.

Moderation analyses :
Sig. (Gender), NS (Race)
Multivariate linear
N/A.
regression . Unadjusted
and adjusted ORs and
95% CIs were calculated
for overweight status
(overweight vs. Not
overweight and obese vs.
not overweight) at C1 on
subsequent depressive
symptoms 1 year later.
Moderation analyses :
NS (Gender)

Self-report BMI .
β= -0.08, p = 0.52.
Measured BMI .
Similar results.
Similar results when using a
obese instead of overweight.

Neither overweight
status nor obese status
at baseline predicted
subsequent depressive
symptoms 1 year later,
regardless of whether
BMI was self-reported
or measured.
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Table 1. Studies examining body mass as a predictor of depressive symptoms (continued).
Author(s),
Year

Xie,
Unger,
Gallaher,
et al.,
2010

Sample
Characteristics

Body Mass
measure

Depressive
Symptoms
measure

Community sample of
middle school students
in Los Angeles
(Asians and Hispanics
only).
Data came from
smoking prevention
trial study.

Measured
H&W.
Categorical
(CDC
referenceoverweight,
not
overweight).

CES-D-5
(SR).
Continuous
(depressive
symptoms).

Sample size : 1155
Baseline age (y) : 12
Follow-up : 2 cycles
over 1 year
Sex : Both

Covariates

Pubertal status, SES,
Smoking status, Age,
Ethnicity, Intervention
group.
Baseline dependent
variable. Controlled in
analyses.
Moderation analyses :
Gender X Overweight,
Race X Overweight,
Acculturation X
Overweight

Analysis type

Unadjusted odds ratio (95% Adjusted odds ratio (95%
confidence interval) or other confidence interval) or other
statistics reported
statistics reported

Multivariate linear
N/A
regression. Multiple
group SEMs to compare
associations of overweight
status (vs. not overweight
status) on subsequent
depressive symptoms;
separately for males and
females, Asians and
Hispanics, and accultured
and not accultured.
Moderation analyses :
Sig. (Gender, Race,
Acculturation)

Observed relationship

Standardized (unstandardized) Asian males who were
parameter estimates.
overweight at baseline
had higher depressive
Girl, Low AC: 0.13 (0.07,
symptoms at follow-up
NS).
than non-overweight
Girl, High AC: -0.14 (-0.07, Asian males. Boys with
NS).
low acculturation who
Boy, Low AC: 0.22 (0.14, p were overweight at
baseline had higher
< .05).
Boy, High AC: 0.06 (0.04,
subsequent depressive
NS).
symptoms compared to
Girl, Asian: -0.26 (-0.09,
their not overweight
NS).
counterparts. No other
Girl, Hispanic: 0.01 (0.01,
significant associations.
NS).
Boy, Asian: 0.26 (0.15, p <
.05).
Boy, Hispanic: 0.12 (0.11,
NS)

CDC classifications: Obesity= greater than or equal to 95th percentile; Overweight = 85th percentile; Not overweight = <85th percentile.
WHO classifications: Obesity = BMI≥30; Overweight = BMI 25-29.99; Normal weight = BMI 18.50-24.99; Underweight = BMI<18.5
SR: self-reported. H&W: height and weight. Sig: significant. AC: Accultured. OR: odds ratio. CI: Confidence interval. CSDS: Clinically significant depressive symptoms. SES: socioeconomic status. NS: not
significant. N/A: not applicable or not analyzed. CDC: Center for Disease Control. BMI: body mass index. WHO: World Health Organization. CES-D: Center for Epidemiological Studies- Depression
Scale. MFQ: Mood and Feeling Questionnaire. SMFQ: Short Mood and Feeling Questionnaire. HSCL = Hopkins Symptom Checklist-25. SE: standard error. K-SADS: Schedule for Affective Disorders
and Schizophrenia for School-Age Children. GEE: generalized estimating equations. SEM: structural equation model.
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Table 2 . Studies examining depressive symptoms as a predictor of body mass.
Author(s), Year

Sample
Characteristics

Anderson,
Random sample
Murray, Johnson, from multi-center
et al., 2011
group-randomized
intervention trial in
middle-school girls
from 6 states in the
US.
Hispanic, nonHispanic black, and
non-Hispanic White
were only included.

Body mass
measure

Measured
H&W.
Categorical
(CDC
referenceobese vs. not
obese).
Continuous
(BMI zscore).

Depressive
symptoms
measure
CES-D (SR).
Categorical
(scores ≥ 24 =
clinically
significant
depressive
symptoms).
Continuous
(depressive
symptoms).

Covariates

Analysis type

Baseline dependent
variable . Controlled in
analyses. Excluded in
analyses.

Multivariate logistic
regression . Unadjusted
and adjusted ORs and
95% CIs were calculated
for CSDS status at C1 on
subsequent obesity status
2 years later.
Multivariate linear
regression using BMI.

Moderation analyses :
Obesity X Race

Moderation analyses :
Sig (Race)

Age, Time typically spent
home alone after school,
Lunch type (free/reduced),
Race .

Unadjusted Adjusted odds ratio (95%
result
confidence interval) or other
statistics reported
Not
adjusted for
baseline
dependent
variable.
White: 4.13
(1.77, 9.64).
Black: 0.82
(0.40, 1.67).
Hispanic:
1.66 (0.58,
4.73)

Sample size : 918
Baseline age (y) :
11
Follow-up : 2
cycles over 2 years.
Sex : Females
Bardone, Moffitt, Cohort of
Caspi, et al.,
adolescents from
1998
New Zealand.
Sample size : 459
Baseline age (y) :
15
Follow-up : 2
cycles over 6 years
Sex : Females

Observed relationship

Depression predicted
subsequent obesity status only
in White females, in both
unadjusted and adjusted
models, controlling for
baseline obesity. In adjusted
models that excluded females
Excluded baseline
with baseline obesity status,
dependent variable.
White: 3.11 (0.85, 11.32). depression did not predict
Black: 1.56 (0.51, 4.72). subsequent obesity onset for
Hispanic: 1.34 (0.12,
any race.
14.81).
Controlled baseline
dependent variable.
White: 3.68 (1.72, 7.87).
Black: 1.58 (0.65, 3.83).
Hispanic: 1.64 (0.36, 7.49).

Results using continuous
variables were consistent
with results using
dichotomous variables
(results not shown).
Measured
H&W.
Continuous
(BMI).

DISC
(Interview).
Categorical
(diagnosis of
MDD or
dysthymia =
depression)

SES, Age at menarche,
Absence of a father figure,
Parental smoking,
Childhood health,
Maternal health, Maternal
BMI, Religiosity, Daughter
of teenage mother.
Baseline dependent
variable. Did not control for
or exclude in analyses.

β = 0.06
Multivariate linear
regression . Unadjusted (NS)
and adjusted coefficients
to estimate influence of
depression (depressed vs.
Not depressed) at age 15
on subsequent BMI at
age 21.

β = 0.05 (NS)

Depression at age 15 did not
predict BMI at age 21, both
before and after covariate
adjustment.
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Table 2 . Studies examining depressive symptoms as a predictor of body mass (continued).
Author(s), Year

Sample
Characteristics

Body mass
measure

Barefoot,
Cohort of University Measured
Heitmann, Heims, of North Carolina H&W at
et al., 1998
students.
baseline. SR
H&W at
Sample size : 4673 follow-up.
Baseline age (y) : Continuous
16-25
(change in
Follow-up : 2
BMI).
cycles over 23 years
Sex: Both

Depressive
symptoms
measure
MMPI ODS
(SR).
Categorical
(scores ≥ 13 for
females and ≥
11 for males =
clinically
significant
depressive
symptoms).
Continuous
(depressive
symptoms).

Covariates

Gender, Exercise,
Smoking.
Baseline dependent
variable. Controlled in
analyses.
Moderation analyses :
Gender X BMI, BMI X
CSDS

Analysis type

Unadjusted Adjusted odds ratio (95%
result
confidence interval) or other
statistics reported

Multivariate linear
N/A
regression . Adjusted
coefficients to estimate
influence of CSDS status
on BMI change between
two cycles.
Moderation analyses :
Sig (All)

β = -19.68, p < 0.001.

Observed relationship

Participants with clinically
significant depressive
symptoms who were initially
lean gained less weight than
lean participants who without
clinically significant depresive
symptoms.
Participants with clinically
significant depressive
symptoms who were intitially
heavy appear to have gained
more weight than heavy
participants without clinically
significant depressive
symptoms.
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Table 2 . Studies examining depressive symptoms as a predictor of body mass (continued).
Author(s), Year

Duarte,
Sourander,
Nikolakaros, et
al., 2010

Sample
Characteristics

Body mass
measure

Measured
H&W.
Categorical
(WHO
classificationSample size : 2209 normal
Baseline age (y) : 8 weight,
Follow-up : 2
overweight,
cycles over 10-15 obese)
years
Sex : Males
National populationbased cohort of
children born in
Finland in 1981.

Depressive
symptoms
measure
CDI (SR).
Categorical
(internal
reference- <
50th percentile =
no CSDS, 50th90th percentile =
moderate
CSDS, > 90th
percentile =
severe CSDS.
Continuous
(number of
symptoms).

Covariates

Analysis type

Unadjusted Adjusted odds ratio (95%
result
confidence interval) or other
statistics reported

Mother's education, Age at Multivariate logistic
N/A
follow-up.
regression . Adjusted
ORs and 95% CIs were
Baseline dependent
calculated for the
variable. Did not control for influence of childhood
or exclude in analyses.
CSDS status on
subsequent weight status
Excluded underweight.
(obese, overweight).

Categorical depressive
symptoms.
Moderate CSDS →
overweight: 1.3 (1.01,
1.7).
Moderate CSDS →
obesity: 1.0 (0.6, 1.6).
Severe CSDS →
overweight: 1.2 (0.8, 1.8).
Severe CSDS → obesity:
0.6 (0.2, 1.4).
Continuous depressive
symptoms .
Overweight: 1.1 (0.98,
1.2);
Obese: 0.9 (0.7, 1.2)

Observed relationship

Children with moderate
clinically significant depressive
symptoms (CSDS) at age 8
were more likely to be
overweight in young
adulthood compared to
children without CSDS after
covariate adjustement.
Nothing significant for
moderate CSDS predicting
obesity, or severe CSDS
predicting overweight/obesity.
With continuous depressive
symptoms, depressive
symtpoms at age 8 years were
not associated with being
overweight or obese.
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Table 2 . Studies examining depressive symptoms as a predictor of body mass (continued).
Author(s), Year

Franko, StriegelMoore,
Thompson, et al.,
2005

Sample
Characteristics

Body mass
measure

SR H&W at
C1, C2.
Measured
H&W at C3.
Categorical
(CDC
referenceSample size : 1554 not obese,
Baseline age (y) : obese; for
~16.5
participants
Follow-up : 3
21 years and
cycles at ages 16, older at
18, and 21
follow-up,
Sex : Females
obese =
BMI ≥ 30).
Continuous
(BMI).
Two communitybased cohorts of
Black and White
girls in 3 US states
(California,
Maryland, Ohio).

Depressive
symptoms
measure
CES-D (SR).
Continuous
(depressive
symptoms).

Covariates

Race (Black/ White), Site
(Ohio/ Maryland/
California), Parental
education.
Baseline dependent
variable . Controlled in
analyses.
Moderation analyses :
Race X Depressive
symptoms

Analysis type

Unadjusted Adjusted odds ratio (95%
confidence interval) or other
result
statistics reported

Multivariate linear
N/A
regression . Adjusted
coefficients to estimate
influence of depressive
symptoms at age 16 and
18 (separate models) on
subsequent BMI at age
21.

Multivariate linear
regression.
Depressive Symptoms at
age 16: β = 0.03 (SE =
.009, p = .002).
Depressive Symptoms at
age 18: β=0.02 (SE =
.008, p = 0.01).

Multivariate logistic
regression. Adjusted
ORs and 95% CIs
calculated for the
influence of depressive
symptoms at age 16 and
18 (separate models) on
subsequent obesity at age
21.

Multivariate logistic
regression.
Depressive Symptoms at
age 16: 3.11 (1.13, 5.12).
Depressive Symptoms at
age 18: 3.50 (1.26, 5.80).

Observed relationship

Higher depressive symptoms
at age 16 or 18 predicted
increased risk of obesity at
age 21, after covariate
adjustment. Same pattern
when BMI was continuous.
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Table 2 . Studies examining depressive symptoms as a predictor of body mass (continued).
Author(s), Year

Goodman &
Whitaker, 2002

Sample
Characteristics

Nationally
representative
cohort of
adolescents in the
US.
Non-Hispanic
White, non-Hispanic
Black, and Hispanic
were included only.

Body mass
measure

SR H&W.
Categorical
(CDC
referencenot obese,
obese; for
participants
20 years and
older at
follow-up,
Sample size : 9374 obese: BMI
Baseline age (y) : ≥ 30).
12-19
Follow-up : 2
cycles over 1 year
Sex : Both

Depressive
symptoms
measure
Modified CESD-18 (SR).
Categorical
(scores ≥ 24 for
females and ≥
22 for males =
clinically
significant
depressive
symptoms).

Covariates

Level 1 covariates: Age,
Gender, Race (White nonHispanic/ Black nonHispanic/ Hispanic),
Parental obesity, Parent
education, Two parents in
the home vs. Other.
Level 2 covariates: Selfesteem, Smoking,
Delinquent behavior, Low
physical activity.
Baseline dependent
variable . Controlled BMI zscore in analyses. Excluded
obese in analyses.
Moderation analyses :
Gender, Self-esteem X
CSDS, Smoking X CSDS,
Delinquent behavior X
CSDS, Low physical activity
X CSDS

Analysis type

Multivariate logistic
regression . Unadjusted
and adjusted ORs and
95% CIs were calculated
for clinically significant
depressive symptoms at
C1 on subsequent obesity
status 1 year later.
Moderation analyses :
Sig (Smoking), NS (All
else)

Unadjusted Adjusted odds ratio (95%
result
confidence interval) or other
statistics reported
12.4% of
those with
CSDS at C1
were obese
at follow-up,
compared
with 9.4% of
those without
CSDS at
baseline (p =
.048).

Observed relationship

Those with clinically significant
depressive symptoms (CSDS)
at baseline had a higher risk of
obesity at follow-up,
compared to those without
CSDS at baseline. Similar
magnitude of effect between
analyses that excluded obese
Level 1 and 2 covariates. at baseline and analyses that
Controlled for baseline BMI controlled for baseline BMI zz-score: did not present
score.
results.
Those with CSDS who
Excluded obese at
smoked heavily were at an
baseline: 2.39 (1.05,
increased risk for worsening
5.45).
obesity, compared to those
who did not smoke.

Level 1 covariates.
Controlled for baseline
BMI z-score: 2.05 (1.18,
3.56).
Excluded obese at
baseline: 2.05 (1.04,
4.06).
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Table 2 . Studies examining depressive symptoms as a predictor of body mass (continued).
Author(s), Year

Sample
Characteristics

Goodwin,
Sourander,
Duarte, et al.,
2009

National populationbased cohort of
children born in
Finland in 1981.

Jansen, van de
Looij-Jansen, de
Wilde, et al.,
2008

Community-based
study of youth in
Rotterdam
(Netherlands).

Body mass
measure

Measured
H&W.
Categorical
(physician
diagnosis of
Sample size: 2712 obesity using
Baseline age (y): 8 ICD-10
Follow-up: 3 cycles criteria).
over 10-15 years
Sex: Males

Depressive
symptoms
measure
CDI (SR).
Categorical
(internal
reference- <
50th percentile =
no CSDS, 50th90th percentile =
moderate
CSDS, > 90th
percentile =
severe CSDS.
Continuous
(number of
symptoms).

SDQC (SR).
Measured
H&W at C1, Categorical
SR H&W at (score ≥ 4 =
C2.
clinically
Categorical significant
depressive
Sample size : 787 (WHO
Baseline age (y) : 9- classifications-symptoms).
not
10
overweight,
Follow-up : 2
cycles over 3 years overweight,
obese).
Sex : Both

Covariates

Analysis type

Mother's education,
Multivariate logistic
Somatic health problems at regression . Unadjusted
age 8.
and adjusted ORs and
95% CIs were calculated
Baseline dependent
for the influence of
variable. Did not control for childhood CSDS status
or exclude in analyses.
on subsequent obesity in
young adulthood.

Unadjusted Adjusted odds ratio (95%
result
confidence interval) or other
statistics reported
Moderate
CSDS: 1.4
(0.9, 2.3).
Severe
CSDS: 0.7
(0.3, 1.8).

N/A
Gender, Country of origin, Multivariate logistic
Level of education.
regression . Adjusted
ORs and 95% CIs were
Baseline dependent
calculated for the
variable . Controlled in
influence of childhood
analyses.
CSDS on subsequent
weight status (obese,
Moderation analyses :
overweight).
Gender X Weight Status
Moderation analyses :
NS (Gender)

Observed relationship

Moderate CSDS: 1.4 (0.9,
2.3).
Severe CSDS: 0.5 (0.2,
1.4).

CSDS in childhood did not
predict increased risk of
obesity in young adulthood,
both before and after
covariate adjustment. Similar
results with continuous
depressive symptoms.

Did not present results.

Clinically significant
depressive symptoms at C1
did not predict weight status 3
years later, after covariate
adjustment.
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Table 2 . Studies examining depressive symptoms as a predictor of body mass (continued).
Author(s), Year

Pine, Cohen,
Brook, et al.,
1997

Rhew,
Richardson,
Lymp, et al.,
2008

Sample
Characteristics

Depressive
symptoms
measure

Covariates

Community-based
study of an
adolescent cohort in
upstate New York.

SR H&W.
Categorical
(internal
referenceobesity =
Sample size : 644 BMI > 80th
Baseline age (y) : 9- percentile).
18
Continuous
Follow-up : 2
(BMI).
cycles over 9 years
Sex : Both

DISC (from
either mother or
child report at
C1, from child
only at C2).
Continuous
(depressive
symptoms).

Age, Ethnicity, Parental
social class, Parental
sociopathy, Physical health
status, Childhood IQ,
Smoking and alcohol use.

Community-based SR H&W.
study of sixth grade Measured
students from public H&W.
Continuous
middle schools in
Seattle, Washington. (BMI).
Oversampled
students scoring high
on depression or
disruptive behavior.

MFQ (SR).
Categorical
(scores ≥ 15 =
clinically
significant
depressive
symptoms).

Gender, Household
income, Education of
primary caregiver,
Physical development,
Race (Black, Pacific
Islander, Other).

Sample size : 446
Baseline age (y) :
~12
Follow-up : 2
cycles over 1 year
Sex: Both

Body mass
measure

Analysis type

Unadjusted Adjusted odds ratio (95%
result
confidence interval) or other
statistics reported

Categorical.
Multivariate linear
regression . Unadjusted Males: 1.46
and adjusted coefficients (0.78, 2.74).
to estimate influence of
Females:
depressive symptoms
3.06 (1.91,
during adolecence on
4.91).
Baseline dependent
subsequent BMI in young
Continuous .
variable. Did not control for adulthood.
Not
or exclude in analyses.
Multivariate logistic
presented.
regression. Adjusted
ORs and 95% CIs
calculated for the
influence of depressive
symptoms during
adolecence on subsequent
BMI in young adulthood.

Baseline dependent
variable. Controlled in
analyses.
Moderation analyses :
Depression X Gender

Multivariate linear
regression . Unadjusted
and adjusted ORs and
95% CIs were calculated
for CSDS at C1 on
subsequent BMI 1 year
later.
Moderation analyses :
Sig (Gender)

Self-report
BMI. Males 0.48 (-1.64,
0.67).
Females:
3.16 (1.91,
4.40).

Categorical.
Not presented.
Continuous.
β = 0.38 ± .19 (p < .05).
When conduct disorder
entered into model: β =
0.15 ± .20 (NS).

Self-report BMI.
Males: β= -1.18 (-1.99, 0.37).
Females: β= 2.49 (1.44,
3.54).

Measured BMI.
Males: β = 0.12 (-0.49,
0.73).
Measured
BMI. Results Females: β = 0.54 (-0.42,
not reported. 1.51).

Observed relationship

Before covariate adjustment,
depressive symptoms during
adolescence predicted young
adult obesity in females, but
not males. In multivariate
associations, depressive
symptoms during adolescence
predicted young adult BMI
only when adolescent conduct
disorder was not included in
the model (males and females
grouped together).

For self-reported BMI, males
with clinically significant
depressive symptoms (CSDS)
at baseline had lower
subsequent BMI compared to
males without CSDS, after
covariate adjustement
(although this association was
not significant before
adjustment). For females,
CSDS at baseline predicted
higher BMI, both before and
after covariate adjustment (for
self-reported BMI). When
BMI was measured,
depression did not predict
subsequent BMI levels.
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Table 2 . Studies examining depressive symptoms as a predictor of body mass (continued).
Author(s), Year

Stice, Presnell,
Shaw, et al.,
2005

Sample
Characteristics

Body mass
measure

Community-based
cohort of adolescent
girls from 4 public
and 4 private
schools in a
metropolitan area of
the southwestern
US.

Measured
H&W.
Categorical
(CDC
classificationobesity).

Sample size : 496
Baseline age (y) :
11-15
Follow-up : 5
annual cycles
Sex : Females

Depressive
symptoms
measure
SADS (SR).
Continuous
(depressive
symptom
severity index).

Covariates

Analysis type

Unadjusted Adjusted odds ratio (95%
result
confidence interval) or other
statistics reported

Dietary restraint,
Multivariate logistic
4.62 (1.67,
Compensatory behaviors, regression . Unadjusted 12.74)
Perceived parental obesity and adjusted ORs and
95% CIs were calculated
Baseline dependent
for depressive symptoms
variable. Excluded at
at C1 on subsequent
baseline.
obesity over the 4-year
follow-up period.

2.32 (0.62, 8.65)

Observed relationship

After covariate adjustment,
depressive symptoms at C1
did not predict obesity onset
during 4-year follow-up
(associations were significant
before adjustment).
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Table 2 . Studies examining depressive symptoms as a predictor of body mass (continued).
Author(s), Year

Sample
Characteristics

Tanofsky-Kraff, Cohort of Black and
Cohen, Yanovski, White children from
et al., 2006
3 Maryland schools,
US, at increased
risk for adult
obesity.
Sample size: 134
Baseline age (y): 612
Follow-up: ~4
annual cycles
(follow-up periods
ranged from 0.1-7.9
years
Sex: Both

Body mass
measure

Measured
DEXA.
Continuous
(fat mass,
change in fat
mass).

Depressive
symptoms
measure
CDI (SR).
Continuous
(depressive
symptoms).

Covariates

Age at baseline, Gender,
Race, SES, Pubertal stage,
Time, Self-reported dieting,
Binge eating, ChEAT total
score.
Baseline dependent
variable . Controlled in
analyses.
Moderation analyses :
Gender X Race, Gender X
Time

Analysis type

Unadjusted Adjusted odds ratio (95%
result
confidence interval) or other
statistics reported

Linear regression.
N/A
Mixed model with
depression as fixed effect
and child as random
effect. Mixed regression
model for predicting
influence of depression at
childhood on increase in
body fat over course of
follow-up.

β = 0.004, SE = 0.005 (0.007, 0.014), p = .45

Observed relationship

Depressive symptoms at
baseline did not predict
increases in body fat mass
over time, after covariate
adjustment.

Moderation analyses: NS
(All)

CDC classifications: Obesity= 95th percentile; Overweight = 85th percentile; Not overweight = <85th percentile.
WHO classifications: Obesity = BMI≥30; Overweight = BMI≥25; Normal weight = BMI 18.50-24.99; Underweight = BMI<18.5
CDI categories: scores <50th percentile = no depression, 50-90th percentile = moderate depression, ≥90th percentile = severe depression
SR: self-reported. H&W: height and weight. C1, C2, etc.,: cycle 1, cycle 2, etc., respectively. N/A: not applicable or not analyzed. SES: socioeconomic status. Sig: significant. NS: not significant. CSDS:
Clinically significant depressive symptoms. OR: odds ratio. CI: confidence interval. IQ: intelligence quotient. CDC: Center for Disease Control. BMI: body mass index. DISC: Diagnostic Interview Schedule
for Children. MDD: major depressive disorder. WHO: World Health Organization. CES-D: Center for Epidemiological Studies- Depression Scale. MMPI-ODS Minnesota Multiphasic Inventory- Obvious
Depression subscale. CDI: Children’s Depression Inventory. ICD-10: International Classification of Diseases-10. SADS: Schedule for Affective Disorders and Schizophrenia. DEXA: Dual-energy X-ray
absorpitiometry. MFQ: Mood and Feelings Questionnaire. SDQC: Short Depression Questionnaire for Children.
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